title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Friday,20220506T160650,https://www.benzinga.com/markets/options/22/05/27050916/52-weeks-high-and-low-article,MGNX,0.005467,Neutral,-0.015607
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,MGNX,0.00644,Neutral,-0.016626
Stocks That Hit 52-Week Lows On Monday,20220613T161842,https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article,MGNX,0.005366,Neutral,0.002664
Stocks That Hit 52-Week Lows On Tuesday,20220524T161351,https://www.benzinga.com/markets/options/22/05/27375519/52-weeks-high-and-low-article,MGNX,0.010175,Neutral,-0.01028
Stocks That Hit 52-Week Lows On Wednesday,20220427T184104,https://www.benzinga.com/markets/options/22/04/26844275/52-weeks-high-and-low-article,MGNX,0.006956,Neutral,-0.004443
"Dianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Chief Scientific Officer - Dianthus Therapeutics  ( NASDAQ:DNTH ) ",20231129T210500,https://www.benzinga.com/pressreleases/23/11/g36011541/dianthus-therapeutics-enhances-leadership-team-with-appointment-of-jeffrey-stavenhagen-ph-d-as-chi,MGNX,0.032691,Neutral,0.08573
Stocks That Hit 52-Week Lows On Thursday,20220526T161527,https://www.benzinga.com/markets/options/22/05/27422270/52-weeks-high-and-low-article,MGNX,0.048646,Neutral,-0.000809
"Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More",20241211T145500,https://www.zacks.com/stock/news/2382213/biotech-stock-roundup-bioa-down-on-study-update-qure-crdf-gain-on-study-data-more,MGNX,0.040145,Somewhat-Bullish,0.196007
Stocks That Hit 52-Week Lows On Thursday,20220602T172744,https://www.benzinga.com/markets/options/22/06/27526024/52-weeks-high-and-low-article,MGNX,0.053402,Neutral,0.012288
Stocks That Hit 52-Week Lows On Wednesday,20220504T162909,https://www.benzinga.com/markets/options/22/05/26995541/52-weeks-high-and-low-article,MGNX,0.012359,Neutral,0.007344
"Earnings Scheduled For May 3, 2022",20220503T085235,https://www.benzinga.com/news/earnings/22/05/26953640/earnings-scheduled-for-may-3-2022,MGNX,0.01558,Neutral,-0.090579
Stocks That Hit 52-Week Lows On Thursday,20220505T153818,https://www.benzinga.com/markets/options/22/05/27026106/52-weeks-high-and-low-article,MGNX,0.015457,Neutral,0.000842
Stocks That Hit 52-Week Lows On Friday,20220610T154524,https://www.benzinga.com/markets/options/22/06/27650434/52-weeks-high-and-low-article,MGNX,0.013393,Neutral,-0.009622
"$1.8 Million Bet On MacroGenics? Check Out These 3 Penny Stocks Insiders Are Buying - Macrogenics  ( NASDAQ:MGNX ) , Black Diamond Therapeutic  ( NASDAQ:BDTX ) ",20221024T195759,https://www.benzinga.com/trading-ideas/long-ideas/22/10/29386174/1-8-million-bet-on-macrogenics-check-out-these-3-penny-stocks-insiders-are-buying,MGNX,0.540042,Somewhat-Bullish,0.295969
Incyte's Late-stage NSCLC Study Meets Primary and Secondary Goals,20241209T181400,https://www.zacks.com/stock/news/2381136/incytes-late-stage-nsclc-study-meets-primary-and-secondary-goals,MGNX,0.05339,Somewhat-Bullish,0.230824
MacroGenics to Participate in Upcoming Investor Conference,20241202T213000,https://www.globenewswire.com/news-release/2024/12/02/2990161/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conference.html,MGNX,0.960101,Neutral,0.093753
MacroGenics to Participate in Upcoming Investor Conference - Macrogenics  ( NASDAQ:MGNX ) ,20241202T213000,https://www.benzinga.com/pressreleases/24/12/g42277566/macrogenics-to-participate-in-upcoming-investor-conference,MGNX,0.92757,Neutral,0.092751
Why Is Incyte  ( INCY )  Up 2.1% Since Last Earnings Report?,20241128T163138,https://www.zacks.com/stock/news/2376668/why-is-incyte-incy-up-21-since-last-earnings-report,MGNX,0.03804,Neutral,0.087589
MacroGenics to Participate in Upcoming Investor Conferences - Macrogenics  ( NASDAQ:MGNX ) ,20241106T213000,https://www.benzinga.com/pressreleases/24/11/g41788310/macrogenics-to-participate-in-upcoming-investor-conferences,MGNX,0.945787,Somewhat-Bullish,0.151795
MacroGenics  ( MGNX )  Q3 2024 Earnings Call Transcript,20241106T031514,https://www.fool.com/earnings/call-transcripts/2024/11/05/macrogenics-mgnx-q3-2024-earnings-call-transcript/,MGNX,0.097954,Neutral,0.138607
MacroGenics  ( MGNX )  Beats Q3 Earnings and Revenue Estimates,20241106T003002,https://www.zacks.com/stock/news/2364825/macrogenics-mgnx-beats-q3-earnings-and-revenue-estimates,MGNX,0.401331,Neutral,0.119663
MacroGenics Announces Leadership Transition,20241030T113000,https://www.globenewswire.com/news-release/2024/10/30/2971590/0/en/MacroGenics-Announces-Leadership-Transition.html,MGNX,0.436009,Somewhat-Bullish,0.258804
MacroGenics Announces Leadership Transition - Macrogenics  ( NASDAQ:MGNX ) ,20241030T113000,https://www.benzinga.com/pressreleases/24/10/g41621635/macrogenics-announces-leadership-transition,MGNX,0.423251,Somewhat-Bullish,0.253847
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call,20241029T203000,https://www.globenewswire.com/news-release/2024/10/29/2971261/0/en/MacroGenics-Announces-Date-of-Third-Quarter-2024-Financial-Results-Conference-Call.html,MGNX,0.841981,Somewhat-Bullish,0.175135
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call - Macrogenics  ( NASDAQ:MGNX ) ,20241029T203000,https://www.benzinga.com/pressreleases/24/10/g41611505/macrogenics-announces-date-of-third-quarter-2024-financial-results-conference-call,MGNX,0.7887,Somewhat-Bullish,0.167018
"INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product Sales",20241029T144700,https://www.zacks.com/stock/news/2359805/incy-q3-earnings-miss-estimates-revenues-beat-on-higher-product-sales,MGNX,0.044801,Neutral,0.089372
Capricor  ( CAPR )  Surges 18.2%: Is This an Indication of Further Gains?,20240924T113700,https://www.zacks.com/stock/news/2340295/capricor-capr-surges-182-is-this-an-indication-of-further-gains,MGNX,0.483888,Neutral,-0.075977
Hagens Berman Alerts MacroGenics  ( MGNX )  Investors to Today's Lead Plaintiff Deadline in Securities Class Action - Macrogenics  ( NASDAQ:MGNX ) ,20240924T104900,https://www.benzinga.com/pressreleases/24/09/g40998256/hagens-berman-alerts-macrogenics-mgnx-investors-to-todays-lead-plaintiff-deadline-in-securities-cl,MGNX,0.729067,Somewhat-Bullish,0.235951
"MGNX DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 24 Deadline in Securities Class Action - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240923T231852,https://www.benzinga.com/pressreleases/24/09/g40993277/mgnx-deadline-tomorrow-rosen-trusted-investor-counsel-encourages-macrogenics-inc-investors-with-lo,MGNX,0.319725,Neutral,-0.043108
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm - Macrogenics  ( NASDAQ:MGNX ) , Vicor  ( NASDAQ:VICR ) ",20240922T010000,https://www.benzinga.com/pressreleases/24/09/g40970200/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-macro,MGNX,0.496597,Neutral,-0.050723
"MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Macrogenics  ( NASDAQ:MGNX ) ",20240920T180000,https://www.benzinga.com/pressreleases/24/09/g40963678/mgnx-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-macrogenics-inc-investors-with-s,MGNX,0.640349,Neutral,-0.126697
"MacroGenics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your Rights - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240919T172900,https://www.benzinga.com/pressreleases/24/09/g40944829/macrogenics-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-before-,MGNX,0.566143,Neutral,-0.048962
"DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics - Macrogenics  ( NASDAQ:MGNX ) ",20240919T135700,https://www.benzinga.com/pressreleases/24/09/g40939930/deadline-reminder-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-macrogenics,MGNX,0.595343,Somewhat-Bullish,0.216687
"The Gross Law Firm Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240918T172100,https://www.benzinga.com/pressreleases/24/09/g40925001/the-gross-law-firm-notifies-macrogenics-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadl,MGNX,0.506613,Somewhat-Bullish,0.19349
"MGNX Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc.  ( MGNX )  Investors of Filing Deadline in Class Action Lawsuit - Macrogenics  ( NASDAQ:MGNX ) ",20240918T154130,https://www.benzinga.com/pressreleases/24/09/g40923040/mgnx-deadline-in-6-days-kessler-topaz-meltzer-check-llp-reminds-macrogenics-inc-mgnx-investors-of-,MGNX,0.616842,Somewhat-Bullish,0.316994
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm - Macrogenics  ( NASDAQ:MGNX ) , Vicor  ( NASDAQ:VICR ) ",20240918T010000,https://www.benzinga.com/pressreleases/24/09/g40911847/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-macro,MGNX,0.496597,Neutral,-0.050723
"ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 24 Deadline in Securities Class Action - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240916T181800,https://www.benzinga.com/pressreleases/24/09/g40884864/rosen-trusted-investor-counsel-encourages-macrogenics-inc-investors-with-losses-in-excess-of-100k-,MGNX,0.319725,Neutral,-0.043108
"MacroGenics  ( MGNX )  Investors Alerted to September 24th Deadline in Securities Class Action, Encouraged to Contact Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ",20240915T200424,https://www.benzinga.com/pressreleases/24/09/g40869714/macrogenics-mgnx-investors-alerted-to-september-24th-deadline-in-securities-class-action-encourage,MGNX,0.729067,Somewhat-Bullish,0.235951
"MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Macrogenics  ( NASDAQ:MGNX ) ",20240915T180000,https://www.benzinga.com/pressreleases/24/09/g40869486/mgnx-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-macrogenics-inc-investors-with-s,MGNX,0.640349,Neutral,-0.126697
MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024,20240915T070000,https://www.globenewswire.com/news-release/2024/09/15/2946281/0/en/MacroGenics-Announces-Updated-Efficacy-Safety-Data-from-TAMARACK-Phase-2-Study-of-Vobra-Duo-in-mCRPC-Patients-at-ESMO-Congress-2024.html,MGNX,0.203604,Neutral,0.068478
MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024 - Macrogenics  ( NASDAQ:MGNX ) ,20240915T070000,https://www.benzinga.com/pressreleases/24/09/g40868190/macrogenics-announces-updated-efficacy-safety-data-from-tamarack-phase-2-study-of-vobra-duo-in-mcr,MGNX,0.198148,Neutral,0.060704
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CAE, MacroGenics, Vicor, and American Airlines and Encourages Investors to Contact the Firm - CAE  ( NYSE:CAE ) , American Airlines Gr  ( NASDAQ:AAL ) ",20240914T010000,https://www.benzinga.com/pressreleases/24/09/g40864089/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-cae-m,MGNX,0.196877,Neutral,-0.02526
"Faruqi & Faruqi Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240913T143300,https://www.benzinga.com/pressreleases/24/09/g40855416/faruqi-faruqi-reminds-macrogenics-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaint,MGNX,0.595343,Somewhat-Bullish,0.216687
Do Options Traders Know Something About MacroGenics  ( MGNX )  Stock We Don't?,20240913T123400,https://www.zacks.com/stock/news/2335686/do-options-traders-know-something-about-macrogenics-mgnx-stock-we-dont,MGNX,0.560594,Neutral,0.102001
"MacroGenics  ( MGNX )  Investors Alerted to September 24th Deadline in Securities Class Action, Encouraged to Contact Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ",20240912T194908,https://www.benzinga.com/pressreleases/24/09/g40842212/macrogenics-mgnx-investors-alerted-to-september-24th-deadline-in-securities-class-action-encourage,MGNX,0.729067,Somewhat-Bullish,0.235951
"Lead Plaintiff Deadline Quickly Approaching in MacroGenics, Inc.  ( MGNX )  Class Action - Shareholders Should Contact Robbins LLP for Information - Macrogenics  ( NASDAQ:MGNX ) ",20240911T185054,https://www.benzinga.com/pressreleases/24/09/g40820679/lead-plaintiff-deadline-quickly-approaching-in-macrogenics-inc-mgnx-class-action-shareholders-shou,MGNX,0.549988,Neutral,0.134378
"Shareholders that lost money on MacroGenics, Inc. ( MGNX )  Urged to Join Class Action - Contact The Gross Law Firm to Learn More - Macrogenics  ( NASDAQ:MGNX ) ",20240910T212100,https://www.benzinga.com/pressreleases/24/09/g40805059/shareholders-that-lost-money-on-macrogenics-inc-mgnx-urged-to-join-class-action-contact-the-gross-,MGNX,0.506613,Somewhat-Bullish,0.19349
"Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against MacroGenics, Inc. - Macrogenics  ( NASDAQ:MGNX ) ",20240910T191900,https://www.benzinga.com/pressreleases/24/09/g40802575/lead-plaintiff-deadline-approaching-kessler-topaz-meltzer-check-llp-announces-deadline-in-securiti,MGNX,0.616842,Somewhat-Bullish,0.31698
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CAE, MacroGenics, Vicor, and American Airlines and Encourages Investors to Contact the Firm - CAE  ( NYSE:CAE ) , American Airlines Gr  ( NASDAQ:AAL ) ",20240910T010000,https://www.benzinga.com/pressreleases/24/09/g40784574/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-cae-m,MGNX,0.196877,Neutral,-0.02526
"MGNX INVETOR ALERT: Kirby McInerney LLP Reminds MacroGenics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit - Macrogenics  ( NASDAQ:MGNX ) ",20240909T203500,https://www.benzinga.com/pressreleases/24/09/g40782109/mgnx-invetor-alert-kirby-mcinerney-llp-reminds-macrogenics-inc-investors-of-upcoming-lead-plaintif,MGNX,0.601928,Somewhat-Bullish,0.240243
"MACROGENICS, INC.  ( NASDAQ: MGNX )  DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline - Macrogenics  ( NASDAQ:MGNX ) ",20240909T194840,https://www.benzinga.com/pressreleases/24/09/g40781034/macrogenics-inc-nasdaq-mgnx-deadline-alert-bernstein-liebhard-llp-reminds-macrogenics-inc-investor,MGNX,0.658245,Neutral,0.105098
"MacroGenics  ( MGNX )  Crashed 28% After Pausing Phase 2 TAMARACK Study, Class Action Accuses Company of Misleading Investors Over Cancer Drug Trial - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ",20240909T181455,https://www.benzinga.com/pressreleases/24/09/g40779733/macrogenics-mgnx-crashed-28-after-pausing-phase-2-tamarack-study-class-action-accuses-company-of-m,MGNX,0.729067,Somewhat-Bullish,0.235951
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024,20240908T231000,https://www.globenewswire.com/news-release/2024/09/08/2942475/0/en/MacroGenics-Announces-TAMARACK-Phase-2-Data-Presentation-at-ESMO-Congress-2024.html,MGNX,0.309107,Neutral,0.097716
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024 - Macrogenics  ( NASDAQ:MGNX ) ,20240908T231000,https://www.benzinga.com/pressreleases/24/09/g40765043/macrogenics-announces-tamarack-phase-2-data-presentation-at-esmo-congress-2024,MGNX,0.299072,Neutral,0.097357
"ROSEN, LEADING INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240908T211800,https://www.benzinga.com/pressreleases/24/09/g40764841/rosen-leading-investor-counsel-encourages-macrogenics-inc-investors-to-secure-counsel-before-impor,MGNX,0.319725,Neutral,-0.043108
"MacroGenics  ( MGNX )  Crashed 28% After Pausing Phase 2 TAMARACK Study, Class Action Accuses Company of Misleading Investors Over Cancer Drug Trial - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ",20240906T161932,https://www.benzinga.com/pressreleases/24/09/g40752913/macrogenics-mgnx-crashed-28-after-pausing-phase-2-tamarack-study-class-action-accuses-company-of-m,MGNX,0.745397,Somewhat-Bullish,0.238059
"ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics - Macrogenics  ( NASDAQ:MGNX ) ",20240906T093800,https://www.benzinga.com/pressreleases/24/09/g40745818/ongoing-deadline-alert-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-macrogenics,MGNX,0.595343,Somewhat-Bullish,0.216687
"Class Action Filed Against MacroGenics, Inc.  ( MGNX )  Seeking Recovery for Investors - Contact Levi & Korsinsky - Macrogenics  ( NASDAQ:MGNX ) ",20240905T164737,https://www.benzinga.com/pressreleases/24/09/g40736320/class-action-filed-against-macrogenics-inc-mgnx-seeking-recovery-for-investors-contact-levi-korsin,MGNX,0.566143,Neutral,-0.048962
"ROSEN, A RANKED AND LEADING FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240904T224715,https://www.benzinga.com/pressreleases/24/09/g40720810/rosen-a-ranked-and-leading-firm-encourages-macrogenics-inc-investors-to-secure-counsel-before-impo,MGNX,0.319725,Neutral,-0.043108
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth,20240904T201500,https://www.globenewswire.com/news-release/2024/09/04/2940919/0/en/NANOBIOTIX-Announces-Two-Key-Supervisory-Board-Additions-Intended-to-Further-Equip-the-Company-for-Sustainable-Long-Term-Growth.html,MGNX,0.031864,Neutral,0.040899
"NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth - 89bio  ( NASDAQ:ETNB ) , Nanobiotix  ( NASDAQ:NBTX ) ",20240904T201500,https://www.benzinga.com/pressreleases/24/09/g40718374/nanobiotix-announces-two-key-supervisory-board-additions-intended-to-further-equip-the-company-for,MGNX,0.03072,Neutral,0.039722
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm - CrowdStrike Holdings  ( NASDAQ:CRWD ) , DXC Technology  ( NYSE:DXC ) ",20240904T010000,https://www.benzinga.com/pressreleases/24/09/g40699189/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-macro,MGNX,0.19931,Neutral,-0.025499
"MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Macrogenics  ( NASDAQ:MGNX ) ",20240903T180000,https://www.benzinga.com/pressreleases/24/09/g40693722/mgnx-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-macrogenics-inc-investors-with-s,MGNX,0.640349,Neutral,-0.126697
MacroGenics  ( MGNX )  Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240902T180555,https://www.benzinga.com/pressreleases/24/09/g40677219/macrogenics-mgnx-accused-of-misleading-investors-over-cancer-drug-trial-hagens-berman,MGNX,0.719473,Somewhat-Bullish,0.189742
"MacroGenics, Inc.  ( MGNX )  Investors: September 24, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP - Macrogenics  ( NASDAQ:MGNX ) ",20240902T142900,https://www.benzinga.com/pressreleases/24/09/g40675464/macrogenics-inc-mgnx-investors-september-24-2024-filing-deadline-in-securities-class-action-contac,MGNX,0.616842,Somewhat-Bullish,0.316994
"ROSEN, A TOP-RANKED LAW FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240901T005400,https://www.benzinga.com/pressreleases/24/08/g40667604/rosen-a-top-ranked-law-firm-encourages-macrogenics-inc-investors-to-secure-counsel-before-importan,MGNX,0.319725,Neutral,-0.043108
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, CrowdStrike, Vicor, and American Airlines and Encourages Investors to Contact the Firm - CrowdStrike Holdings  ( NASDAQ:CRWD ) , American Airlines Gr  ( NASDAQ:AAL ) ",20240831T010000,https://www.benzinga.com/pressreleases/24/08/g40664811/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-macro,MGNX,0.2256,Neutral,-0.028102
"MacroGenics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 24, 2024 Deadline to file Lead Plaintiff Motion. - Macrogenics  ( NASDAQ:MGNX ) ",20240830T192040,https://www.benzinga.com/pressreleases/24/08/g40660561/macrogenics-inc-investors-please-contact-the-portnoy-law-firm-to-recover-your-losses-september-24-,MGNX,0.695399,Somewhat-Bullish,0.248048
MacroGenics  ( MGNX )  Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240829T170917,https://www.benzinga.com/pressreleases/24/08/g40631779/macrogenics-mgnx-accused-of-misleading-investors-over-cancer-drug-trial-hagens-berman,MGNX,0.719473,Somewhat-Bullish,0.193553
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, CrowdStrike, Vicor, and American Airlines and Encourages Investors to Contact the Firm - CrowdStrike Holdings  ( NASDAQ:CRWD ) , American Airlines Gr  ( NASDAQ:AAL ) ",20240827T010000,https://www.benzinga.com/pressreleases/24/08/g40566851/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-macro,MGNX,0.2256,Neutral,-0.028102
"ROSEN, LEADING INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240826T235600,https://www.benzinga.com/pressreleases/24/08/g40566421/rosen-leading-investor-counsel-encourages-macrogenics-inc-investors-to-secure-counsel-before-impor,MGNX,0.319725,Neutral,-0.043108
MacroGenics  ( MGNX )  Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240826T194025,https://www.benzinga.com/pressreleases/24/08/g40561577/macrogenics-mgnx-accused-of-misleading-investors-over-cancer-drug-trial-hagens-berman,MGNX,0.719473,Somewhat-Bullish,0.189742
"MacroGenics, Inc.  ( MGNX )  Investors: September 24, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP - Macrogenics  ( NASDAQ:MGNX ) ",20240825T141300,https://www.benzinga.com/pressreleases/24/08/g40543650/macrogenics-inc-mgnx-investors-september-24-2024-filing-deadline-in-securities-class-action-contac,MGNX,0.616842,Somewhat-Bullish,0.316994
"MGNX INVETOR ALERT: Kirby McInerney LLP Reminds MacroGenics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit - Macrogenics  ( NASDAQ:MGNX ) ",20240823T213700,https://www.benzinga.com/pressreleases/24/08/g40537810/mgnx-invetor-alert-kirby-mcinerney-llp-reminds-macrogenics-inc-investors-of-upcoming-lead-plaintif,MGNX,0.601928,Somewhat-Bullish,0.240243
MacroGenics  ( MGNX )  Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240822T191619,https://www.benzinga.com/pressreleases/24/08/g40515563/macrogenics-mgnx-accused-of-misleading-investors-over-cancer-drug-trial-hagens-berman,MGNX,0.719473,Somewhat-Bullish,0.189742
"MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Macrogenics  ( NASDAQ:MGNX ) ",20240822T180000,https://www.benzinga.com/pressreleases/24/08/g40514251/mgnx-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-macrogenics-inc-investors-with-s,MGNX,0.640349,Neutral,-0.126697
"ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240821T212300,https://www.benzinga.com/pressreleases/24/08/g40496011/rosen-a-trusted-and-leading-law-firm-encourages-macrogenics-inc-investors-to-secure-counsel-before,MGNX,0.279015,Somewhat-Bullish,0.164573
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm - Macrogenics  ( NASDAQ:MGNX ) , American Airlines Gr  ( NASDAQ:AAL ) ",20240821T010000,https://www.benzinga.com/pressreleases/24/08/g40476557/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-macro,MGNX,0.28664,Neutral,-0.034078
"Robbins LLP Reminds MacroGenics, Inc.  ( MGNXX )  Investors of the Class Action Lawsuit and Pending Lead Plaintiff Deadline - Macrogenics  ( NASDAQ:MGNX ) ",20240820T204732,https://www.benzinga.com/pressreleases/24/08/g40473923/robbins-llp-reminds-macrogenics-inc-mgnxx-investors-of-the-class-action-lawsuit-and-pending-lead-p,MGNX,0.549988,Neutral,0.141199
"MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Macrogenics  ( NASDAQ:MGNX ) ",20240820T163000,https://www.benzinga.com/pressreleases/24/08/g40468094/mgnx-investors-have-opportunity-to-lead-macrogenics-inc-securities-fraud-lawsuit-with-the-schall-l,MGNX,0.518708,Somewhat-Bearish,-0.332775
MacroGenics  ( MGNX )  Under Fire as Analyst Downgrade Deepens Crisis - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240819T203712,https://www.benzinga.com/pressreleases/24/08/g40450001/macrogenics-mgnx-under-fire-as-analyst-downgrade-deepens-crisis-hagens-berman,MGNX,0.638317,Somewhat-Bearish,-0.162912
"TOP RANKED ROSEN LAW FIRM Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240818T162046,https://www.benzinga.com/pressreleases/24/08/g40431730/top-ranked-rosen-law-firm-encourages-macrogenics-inc-investors-to-secure-counsel-before-important-,MGNX,0.279015,Somewhat-Bullish,0.164573
"Kessler Topaz Meltzer & Check, LLP Encourages MacroGenics, Inc. Investors with Losses to Contact the Firm - Macrogenics  ( NASDAQ:MGNX ) ",20240817T192900,https://www.benzinga.com/pressreleases/24/08/g40429960/kessler-topaz-meltzer-check-llp-encourages-macrogenics-inc-investors-with-losses-to-contact-the-fi,MGNX,0.616842,Somewhat-Bullish,0.316994
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DXC, CrowdStrike, MacroGenics, and Five Below and Encourages Investors to Contact the Firm - CrowdStrike Holdings  ( NASDAQ:CRWD ) , DXC Technology  ( NYSE:DXC ) ",20240817T010000,https://www.benzinga.com/pressreleases/24/08/g40427641/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-dxc-c,MGNX,0.19931,Neutral,-0.025499
"MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Macrogenics  ( NASDAQ:MGNX ) ",20240816T180000,https://www.benzinga.com/pressreleases/24/08/g40422825/mgnx-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-macrogenics-inc-investors-with-s,MGNX,0.640349,Neutral,-0.126697
MacroGenics  ( MGNX )  Under Fire as Analyst Downgrade Deepens Crisis - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240815T181941,https://www.benzinga.com/pressreleases/24/08/g40402965/macrogenics-mgnx-under-fire-as-analyst-downgrade-deepens-crisis-hagens-berman,MGNX,0.638317,Somewhat-Bearish,-0.162912
"MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Macrogenics  ( NASDAQ:MGNX ) ",20240814T144000,https://www.benzinga.com/pressreleases/24/08/g40369766/mgnx-investors-have-opportunity-to-lead-macrogenics-inc-securities-fraud-lawsuit-with-the-schall-l,MGNX,0.518708,Somewhat-Bearish,-0.332775
"MGNX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Case - Macrogenics  ( NASDAQ:MGNX ) ",20240813T044527,https://www.benzinga.com/pressreleases/24/08/g40329412/mgnx-investor-notice-robbins-geller-rudman-dowd-llp-announces-that-macrogenics-inc-investors-with-,MGNX,0.889784,Neutral,0.025785
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DXC, CrowdStrike, MacroGenics, and Five Below and Encourages Investors to Contact the Firm - CrowdStrike Holdings  ( NASDAQ:CRWD ) , DXC Technology  ( NYSE:DXC ) ",20240813T010000,https://www.benzinga.com/pressreleases/24/08/g40328255/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-dxc-c,MGNX,0.19931,Neutral,-0.025499
"MACROGENICS, INC.  ( NASDAQ: MGNX )  DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline - Macrogenics  ( NASDAQ:MGNX ) ",20240812T172823,https://www.benzinga.com/pressreleases/24/08/g40320082/macrogenics-inc-nasdaq-mgnx-deadline-alert-bernstein-liebhard-llp-reminds-macrogenics-inc-investor,MGNX,0.658245,Neutral,0.105098
"MacroGenics  ( MGNX )  Halts Prostate Cancer Trial After Fatal Adverse Events, Investor Suit - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ",20240812T142055,https://www.benzinga.com/pressreleases/24/08/g40314952/macrogenics-mgnx-halts-prostate-cancer-trial-after-fatal-adverse-events-investor-suit-hagens-berma,MGNX,0.735092,Neutral,0.051522
"MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Macrogenics  ( NASDAQ:MGNX ) ",20240811T180000,https://www.benzinga.com/pressreleases/24/08/g40303906/mgnx-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-macrogenics-inc-investors-with-s,MGNX,0.642187,Neutral,-0.126909
"Class Action Announcement for MacroGenics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against MacroGenics, Inc. - Contact Kessler Topaz Meltzer & Check, LLP - Macrogenics  ( NASDAQ:MGNX ) ",20240809T210000,https://www.benzinga.com/pressreleases/24/08/g40296588/class-action-announcement-for-macrogenics-inc-investors-a-securities-fraud-class-action-lawsuit-wa,MGNX,0.616842,Somewhat-Bullish,0.31698
"ROSEN, A LEADING NATIONAL FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240809T172613,https://www.benzinga.com/pressreleases/24/08/g40291363/rosen-a-leading-national-firm-encourages-macrogenics-inc-investors-to-secure-counsel-before-import,MGNX,0.279015,Somewhat-Bullish,0.164573
"Kirby McInerney LLP Reminds MacroGenics, Inc.  ( MGNX )  Investors of Class Action Filing and Encourages Investors to Contact the Firm - Macrogenics  ( NASDAQ:MGNX ) ",20240807T214600,https://www.benzinga.com/pressreleases/24/08/g40237887/kirby-mcinerney-llp-reminds-macrogenics-inc-mgnx-investors-of-class-action-filing-and-encourages-i,MGNX,0.586747,Neutral,0.136206
"MacroGenics, Inc. Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240807T203133,https://www.benzinga.com/pressreleases/24/08/g40234484/macrogenics-inc-class-action-alert-robbins-llp-reminds-investors-of-the-lead-plaintiff-deadline-in,MGNX,0.549988,Neutral,0.134378
"MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Macrogenics  ( NASDAQ:MGNX ) ",20240807T154000,https://www.benzinga.com/pressreleases/24/08/g40225994/mgnx-investors-have-opportunity-to-lead-macrogenics-inc-securities-fraud-lawsuit-with-the-schall-l,MGNX,0.518708,Somewhat-Bearish,-0.332775
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings,20240807T125005,https://www.zacks.com/stock/news/2317812/want-better-returns-dont-ignore-these-2-medical-stocks-set-to-beat-earnings,MGNX,0.266101,Somewhat-Bullish,0.285689
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vicor, American Airlines, and MacroGenics and Encourages Investors to Contact the Firm - Macrogenics  ( NASDAQ:MGNX ) , American Airlines Gr  ( NASDAQ:AAL ) ",20240807T010000,https://www.benzinga.com/pressreleases/24/08/g40208767/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-vicor,MGNX,0.331765,Neutral,-0.038248
"MacroGenics  ( MGNX )  Reports Q2 Loss, Lags Revenue Estimates",20240806T213004,https://www.zacks.com/stock/news/2317378/macrogenics-mgnx-reports-q2-loss-lags-revenue-estimates,MGNX,0.404563,Neutral,0.044202
"MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results - Macrogenics  ( NASDAQ:MGNX ) ",20240806T200141,https://www.benzinga.com/pressreleases/24/08/g40201246/macrogenics-provides-update-on-corporate-progress-second-quarter-2024-financial-results,MGNX,0.397098,Neutral,0.100676
MacroGenics  ( MGNX )  Faces Class Action After Revealing Investigation of Patient Deaths in TAMARACK Study of Vobra Duo - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240805T194227,https://www.benzinga.com/pressreleases/24/08/g40170179/macrogenics-mgnx-faces-class-action-after-revealing-investigation-of-patient-deaths-in-tamarack-st,MGNX,0.74725,Somewhat-Bullish,0.269839
"MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Macrogenics  ( NASDAQ:MGNX ) ",20240805T180000,https://www.benzinga.com/pressreleases/24/08/g40168321/mgnx-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-macrogenics-inc-investors-with-s,MGNX,0.642187,Neutral,-0.126909
"SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc. - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240803T155800,https://www.benzinga.com/pressreleases/24/08/g40147075/shareholder-alert-pomerantz-law-firm-announces-the-filing-of-a-class-action-against-macrogenics-in,MGNX,0.68732,Somewhat-Bullish,0.158928
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vicor and MacroGenics and Encourages Investors to Contact the Firm - Macrogenics  ( NASDAQ:MGNX ) , Vicor  ( NASDAQ:VICR ) ",20240803T010000,https://www.benzinga.com/pressreleases/24/08/g40144640/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-vicor,MGNX,0.496597,Neutral,-0.050723
MacroGenics  ( MGNX )  Class Action Lawsuit Alert: Johnson Fistel Announces Shareholders with Substantial Losses Have the Opportunity to Lead the Action - Macrogenics  ( NASDAQ:MGNX ) ,20240802T201920,https://www.benzinga.com/pressreleases/24/08/g40141664/macrogenics-mgnx-class-action-lawsuit-alert-johnson-fistel-announces-shareholders-with-substantial,MGNX,0.390092,Neutral,-0.094537
MacroGenics  ( MGNX )  Faces Class Action After Revealing Investigation of Patient Deaths in TAMARACK Study of Vobra Duo - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240802T191947,https://www.benzinga.com/pressreleases/24/08/g40140186/macrogenics-mgnx-faces-class-action-after-revealing-investigation-of-patient-deaths-in-tamarack-st,MGNX,0.74725,Somewhat-Bullish,0.269839
"Class Action Announcement for MacroGenics, Inc.  ( MGNX ) : Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. - Macrogenics  ( NASDAQ:MGNX ) ",20240801T151700,https://www.benzinga.com/pressreleases/24/08/g40105617/class-action-announcement-for-macrogenics-inc-mgnx-kessler-topaz-meltzer-check-llp-announces-that-,MGNX,0.628066,Somewhat-Bullish,0.31968
"MACROGENICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against MacroGenics, Inc. - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240801T025300,https://www.benzinga.com/pressreleases/24/07/g40088572/macrogenics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-le,MGNX,0.622414,Neutral,0.073255
"After Reporting Five Patient Deaths, Data Committee Recommends MacroGenics Halt Prostate Cancer Trial - Macrogenics  ( NASDAQ:MGNX ) ",20240731T174520,https://www.benzinga.com/general/biotech/24/07/40077307/after-reporting-five-patient-deaths-data-committee-recommends-macrogenics-halt-prostate-cancer-tr,MGNX,0.82082,Neutral,0.064814
"MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Macrogenics  ( NASDAQ:MGNX ) ",20240731T162000,https://www.benzinga.com/pressreleases/24/07/g40074966/mgnx-investors-have-opportunity-to-lead-macrogenics-inc-securities-fraud-lawsuit-with-the-schall-l,MGNX,0.518708,Somewhat-Bearish,-0.332775
"Pinterest Issues Weak Revenue Forecast, Joins Groupon, O-I Glass And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Pinterest  ( NYSE:PINS ) ",20240731T122751,https://www.benzinga.com/trading-ideas/movers/24/07/40066422/pinterest-issues-weak-revenue-forecast-joins-groupon-o-i-glass-and-other-big-stocks-moving-l,MGNX,0.18967,Neutral,-0.030751
Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Advanced Micro Devices  ( NASDAQ:AMD ) ,20240731T094600,https://www.benzinga.com/trading-ideas/movers/24/07/40061374/why-amd-shares-are-trading-higher-by-over-9-here-are-20-stocks-moving-premarket,MGNX,0.140485,Neutral,-0.025157
"Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against MacroGenics, Inc.  ( MGNX )  - Macrogenics  ( NASDAQ:MGNX ) ",20240731T021827,https://www.benzinga.com/pressreleases/24/07/g40056936/shareholder-alert-robbins-llp-informs-investors-of-the-class-action-filed-against-macrogenics-inc-,MGNX,0.549988,Neutral,0.134378
"MACROGENICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. and Encourages Investors to Contact the Firm - Macrogenics  ( NASDAQ:MGNX ) ",20240731T010000,https://www.benzinga.com/pressreleases/24/07/g40056305/macrogenics-alert-bragar-eagel-squire-p-c-announces-that-a-class-action-lawsuit-has-been-filed-aga,MGNX,0.620415,Neutral,0.02554
"ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX - Macrogenics  ( NASDAQ:MGNX ) ",20240730T234400,https://www.benzinga.com/pressreleases/24/07/g40055489/rosen-nationally-regarded-investor-counsel-encourages-macrogenics-inc-investors-to-secure-counsel-,MGNX,0.319725,Neutral,-0.019149
"MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Macrogenics  ( NASDAQ:MGNX ) ",20240730T180000,https://www.benzinga.com/pressreleases/24/07/g40047408/mgnx-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-macrogenics-inc-investors-with-s,MGNX,0.642187,Neutral,-0.126909
"Contact The Gross Law Firm by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc. ( MGNX )  - Macrogenics  ( NASDAQ:MGNX ) ",20240730T162700,https://www.benzinga.com/pressreleases/24/07/g40045188/contact-the-gross-law-firm-by-september-24-2024-deadline-to-join-class-action-against-macrogenics-,MGNX,0.506613,Somewhat-Bullish,0.19349
MacroGenics  ( MGNX )  Faces Class Action After Revealing Investigation of Patient Deaths in TAMARACK Study of Vobra Duo - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240730T153656,https://www.benzinga.com/pressreleases/24/07/g40043796/macrogenics-mgnx-faces-class-action-after-revealing-investigation-of-patient-deaths-in-tamarack-st,MGNX,0.768309,Somewhat-Bullish,0.166808
"MGNX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead the MacroGenics Class Action Lawsuit - Macrogenics  ( NASDAQ:MGNX ) ",20240729T184929,https://www.benzinga.com/pressreleases/24/07/g40020372/mgnx-investor-alert-robbins-geller-rudman-dowd-llp-announces-that-macrogenics-inc-investors-with-s,MGNX,0.890607,Neutral,0.0043
"MACROGENICS, INC.  ( NASDAQ: MGNX )  INVESTOR ALERT: Investors With Large Losses in MacroGenics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - Macrogenics  ( NASDAQ:MGNX ) ",20240729T171001,https://www.benzinga.com/pressreleases/24/07/g40018128/macrogenics-inc-nasdaq-mgnx-investor-alert-investors-with-large-losses-in-macrogenics-inc-should-c,MGNX,0.491255,Neutral,-0.131074
"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Macrogenics, Inc.  ( MGNX )  Investors - Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Macrogenics  ( NASDAQ:MGNX ) ",20240729T164406,https://www.benzinga.com/pressreleases/24/07/g40017509/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-macrogenics-inc-mgnx-investors-holzer-ho,MGNX,0.619618,Somewhat-Bearish,-0.208399
MacroGenics ALERT: Securities Fraud Lawsuit Could Allow Investors to Recover Losses; Block & Leviton Encourages Investors to Contact the Firm to Learn More - Macrogenics  ( NASDAQ:MGNX ) ,20240729T153904,https://www.benzinga.com/pressreleases/24/07/g40016184/macrogenics-alert-securities-fraud-lawsuit-could-allow-investors-to-recover-losses-block-leviton-e,MGNX,0.670742,Neutral,-0.019125
"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of MacroGenics, Inc. Securities and Sets a Lead Plaintiff Deadline of September 24, 2024 - Macrogenics  ( NASDAQ:MGNX ) ",20240727T000014,https://www.benzinga.com/pressreleases/24/07/g39996515/shareholder-alert-levi-korsinsky-llp-notifies-investors-it-has-filed-a-complaint-to-recover-losses,MGNX,0.514619,Somewhat-Bullish,0.267852
"DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session - DexCom  ( NASDAQ:DXCM ) ",20240726T120515,https://www.benzinga.com/news/24/07/39982144/dexcom-zynex-olin-and-other-big-stocks-moving-lower-in-fridays-pre-market-session,MGNX,0.227007,Bullish,0.45715
Boston Scientific  ( BSX )  Surpasses Q2 Earnings and Revenue Estimates,20240724T114004,https://www.zacks.com/stock/news/2307523/boston-scientific-bsx-surpasses-q2-earnings-and-revenue-estimates,MGNX,0.20997,Neutral,0.0
Investigation Into MacroGenics  ( MGNX )  Announced by Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240719T125500,https://www.benzinga.com/pressreleases/24/07/g39858738/investigation-into-macrogenics-mgnx-announced-by-hagens-berman,MGNX,0.800874,Neutral,0.13826
"MacroGenics  ( MGNX )  Investigating Three of Five Patient Deaths in TAMARACK Study of Vobra Duo, Stock Flat After May 10, 2024 Crash - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ",20240710T211928,https://www.benzinga.com/pressreleases/24/07/g39719658/macrogenics-mgnx-investigating-three-of-five-patient-deaths-in-tamarack-study-of-vobra-duo-stock-f,MGNX,0.802624,Neutral,0.138372
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX",20240707T190000,https://www.benzinga.com/pressreleases/24/07/g39657179/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-macrogenics-inc,MGNX,0.725935,Somewhat-Bullish,0.155741
"MacroGenics  ( MGNX )  Investigating Three of Five Patient Deaths in TAMARACK Study of Vobra Duo, Stock Flat After May 10, 2024 Crash - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ",20240703T213459,https://www.benzinga.com/pressreleases/24/07/g39626617/macrogenics-mgnx-investigating-three-of-five-patient-deaths-in-tamarack-study-of-vobra-duo-stock-f,MGNX,0.800874,Neutral,0.13826
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX",20240630T155700,https://www.benzinga.com/pressreleases/24/06/g39565418/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-macrogenics-inc,MGNX,0.725935,Somewhat-Bullish,0.155741
"MacroGenics, Inc. Investors: Company Investigated by the Portnoy Law Firm",20240624T191332,https://www.benzinga.com/pressreleases/24/06/g39464797/macrogenics-inc-investors-company-investigated-by-the-portnoy-law-firm,MGNX,0.708701,Somewhat-Bullish,0.180144
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX",20240622T205100,https://www.benzinga.com/pressreleases/24/06/g39445823/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-macrogenics-inc,MGNX,0.741116,Somewhat-Bullish,0.157082
MacroGenics  ( MGNX )  Stock Crashes After Reporting Patient Deaths in TAMARACK Study - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240620T172829,https://www.benzinga.com/pressreleases/24/06/g39418653/macrogenics-mgnx-stock-crashes-after-reporting-patient-deaths-in-tamarack-study-hagens-berman,MGNX,0.834422,Neutral,-0.008323
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX",20240615T121500,https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-macrogenics-inc---mgnx-302172528.html,MGNX,0.802374,Somewhat-Bullish,0.225147
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX",20240613T203606,https://www.benzinga.com/pressreleases/24/06/g39322333/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-macrogenics-inc,MGNX,0.725935,Somewhat-Bullish,0.155741
MacroGenics  ( MGNX )  Stock Crashes After Reporting Patient Deaths in TAMARACK Study - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240613T162903,https://www.benzinga.com/pressreleases/24/06/g39317186/macrogenics-mgnx-stock-crashes-after-reporting-patient-deaths-in-tamarack-study-hagens-berman,MGNX,0.834422,Neutral,-0.008323
MacroGenics to Participate in Upcoming Investor Conference,20240611T114500,https://www.globenewswire.com/news-release/2024/06/11/2896693/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conference.html,MGNX,0.958731,Neutral,0.093713
MacroGenics to Participate in Upcoming Investor Conference - Macrogenics  ( NASDAQ:MGNX ) ,20240611T114500,https://www.benzinga.com/pressreleases/24/06/g39267723/macrogenics-to-participate-in-upcoming-investor-conference,MGNX,0.947763,Neutral,0.09335
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX",20240607T174500,https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-macrogenics-inc---mgnx-302167157.html,MGNX,0.802374,Somewhat-Bullish,0.225147
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX",20240605T201657,https://www.benzinga.com/pressreleases/24/06/g39193778/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-macrogenics-inc,MGNX,0.725935,Somewhat-Bullish,0.155741
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Science Applications Intl  ( NASDAQ:SAIC ) ,20240603T175653,https://www.benzinga.com/news/24/06/39143340/why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-i,MGNX,0.074926,Neutral,0.0
MacroGenics  ( MGNX )  Stock Crashes After Reporting Patient Deaths in TAMARACK Study - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240529T164417,https://www.benzinga.com/pressreleases/24/05/g39069295/macrogenics-mgnx-stock-crashes-after-reporting-patient-deaths-in-tamarack-study-hagens-berman,MGNX,0.834422,Neutral,-0.008325
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MacroGenics, Inc. - MGNX",20240528T194105,https://www.benzinga.com/pressreleases/24/05/g39046095/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-macrogenics-inc,MGNX,0.725935,Somewhat-Bullish,0.155741
Demystifying Macrogenics: Insights From 14 Analyst Reviews,20240524T191957,https://markets.businessinsider.com/news/stocks/demystifying-macrogenics-insights-from-14-analyst-reviews-1033421043,MGNX,0.347754,Neutral,0.067124
MacroGenics  ( MGNX )  Stock Crashes After Reporting Patient Deaths in TAMARACK Study - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240516T165941,https://www.benzinga.com/pressreleases/24/05/g38879326/macrogenics-mgnx-stock-crashes-after-reporting-patient-deaths-in-tamarack-study-hagens-berman,MGNX,0.839757,Neutral,-0.008342
"MACROGENICS ALERT: Bragar Eagel & Squire, P.C. is Investigating MacroGenics, Inc. on Behalf of MacroGenics Stockholders and Encourages Investors to Contact the Firm - Macrogenics  ( NASDAQ:MGNX ) ",20240515T010000,https://www.benzinga.com/pressreleases/24/05/g38833730/macrogenics-alert-bragar-eagel-squire-p-c-is-investigating-macrogenics-inc-on-behalf-of-macrogenic,MGNX,0.822443,Neutral,-0.078377
MacroGenics  ( MGNX )  Stock Crashes After Reporting Patient Deaths in TAMARACK Study - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240513T163058,https://www.benzinga.com/pressreleases/24/05/g38795657/macrogenics-mgnx-stock-crashes-after-reporting-patient-deaths-in-tamarack-study-hagens-berman,MGNX,0.834422,Neutral,-0.008323
MacroGenics to Participate in Upcoming Investor Conferences - Macrogenics  ( NASDAQ:MGNX ) ,20240513T113000,https://www.benzinga.com/pressreleases/24/05/g38785307/macrogenics-to-participate-in-upcoming-investor-conferences,MGNX,0.917585,Neutral,0.11724
MacroGenics  ( MGNX )  Stock Crashes After Reporting Patient Deaths in TAMARACK Study - Hagens Berman - Macrogenics  ( NASDAQ:MGNX ) ,20240510T220153,https://www.benzinga.com/pressreleases/24/05/g38772961/macrogenics-mgnx-stock-crashes-after-reporting-patient-deaths-in-tamarack-study-hagens-berman,MGNX,0.841536,Neutral,-0.008348
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths' - Macrogenics  ( NASDAQ:MGNX ) ,20240510T190803,https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38768977/macrogenics-gets-downgraded-following-disappointing-prostate-cancer-trial-results-w,MGNX,0.582526,Somewhat-Bearish,-0.277183
Crude Oil Down 1%; Sweetgreen Shares Spike Higher - Macrogenics  ( NASDAQ:MGNX ) ,20240510T183023,https://www.benzinga.com/news/24/05/38768201/crude-oil-down-1-sweetgreen-shares-spike-higher,MGNX,0.15347,Somewhat-Bullish,0.175227
Nasdaq Moves Lower; US Consumer Sentiment Falls In May - Novavax  ( NASDAQ:NVAX ) ,20240510T162224,https://www.benzinga.com/news/earnings/24/05/38765474/nasdaq-moves-lower-us-consumer-sentiment-falls-in-may,MGNX,0.16171,Somewhat-Bullish,0.181043
Why Is MacroGenics Stock Nosediving On Friday? - Macrogenics  ( NASDAQ:MGNX ) ,20240510T144637,https://www.benzinga.com/general/biotech/24/05/38762671/macrogenics-shares-tumble-after-reporting-adverse-events-multiple-deaths-in-cancer-drug-trial,MGNX,0.570165,Somewhat-Bearish,-0.228095
"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors to Contact the Firm - Macrogenics  ( NASDAQ:MGNX ) ",20240510T141336,https://www.benzinga.com/pressreleases/24/05/g38761892/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-macrogenics-i,MGNX,0.669956,Bearish,-0.373101
"Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings - Dnow  ( NYSE:DNOW ) , Evolv Technologies  ( NASDAQ:EVLV ) ",20240510T140059,https://www.benzinga.com/news/24/05/38761518/dow-jumps-over-100-points-dnow-posts-downbeat-earnings,MGNX,0.151064,Somewhat-Bullish,0.173569
Why Natera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Natera  ( NASDAQ:NTRA ) ,20240510T124422,https://www.benzinga.com/news/24/05/38759503/why-natera-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket,MGNX,0.140896,Neutral,0.140911
"Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Akamai Techs  ( NASDAQ:AKAM ) ",20240510T094515,https://www.benzinga.com/news/24/05/38754753/akamai-technologies-issues-weak-outlook-joins-applied-optoelectronics-jfrog-and-other-big-stocks-mov,MGNX,0.202366,Neutral,-0.063607
MacroGenics  ( MGNX )  Q1 2024 Earnings Call Transcript,20240510T061510,https://www.fool.com/earnings/call-transcripts/2024/05/10/macrogenics-mgnx-q1-2024-earnings-call-transcript/,MGNX,0.038504,Neutral,0.05054
"MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data - Macrogenics  ( NASDAQ:MGNX ) ",20240509T200113,https://www.benzinga.com/pressreleases/24/05/g38743002/macrogenics-provides-update-on-corporate-progress-first-quarter-2024-financial-results-and-interim,MGNX,0.387875,Somewhat-Bullish,0.186034
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call,20240503T113000,https://www.globenewswire.com/news-release/2024/05/03/2875050/0/en/MacroGenics-Announces-Date-of-First-Quarter-2024-Financial-Results-Conference-Call.html,MGNX,0.844427,Somewhat-Bullish,0.175312
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call - Macrogenics  ( NASDAQ:MGNX ) ,20240503T113000,https://www.benzinga.com/pressreleases/24/05/g38610608/macrogenics-announces-date-of-first-quarter-2024-financial-results-conference-call,MGNX,0.791081,Somewhat-Bullish,0.167211
"Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82% - Shift4 Payments  ( NYSE:FOUR ) , Hyundai Motor  ( OTC:HYMTF ) ",20240405T061554,https://www.benzinga.com/markets/equities/24/04/38104998/look-out-for-these-6-stocks-as-analysts-predicts-major-gains-one-up-to-82,MGNX,0.303175,Somewhat-Bullish,0.291036
MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidate Why Is MacroGenics Stock Trading Higher Today? - Macrogenics  ( NASDAQ:MGNX ) ,20240404T181559,https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38098131/macrogenics-analyst-impressed-by-improved-safety-profile-from-prostate-cancer-candi,MGNX,0.298264,Neutral,-0.098442
"Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session - BlackBerry  ( NYSE:BB ) , Simulations Plus  ( NASDAQ:SLP ) , Levi Strauss  ( NYSE:LEVI ) ",20240404T091840,https://www.benzinga.com/news/24/04/38085469/simulations-plus-posts-upbeat-joins-levi-strauss-blackberry-and-other-big-stocks-moving-higher-in-th,MGNX,0.340915,Neutral,0.0
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures,20240403T203000,https://www.globenewswire.com/news-release/2024/04/03/2857385/0/en/MacroGenics-Provides-Phase-2-TAMARACK-Study-Early-Interim-Safety-Data-and-Plans-for-Future-Disclosures.html,MGNX,0.247558,Neutral,0.068453
Biotech ETFs to Watch,20240311T211500,https://investingnews.com/daily/life-science-investing/biotech-investing/small-biotech-etfs/,MGNX,0.075635,Neutral,0.038335
MacroGenics  ( MGNX )  Q4 2023 Earnings Call Transcript,20240308T053017,https://www.fool.com/earnings/call-transcripts/2024/03/08/macrogenics-mgnx-q4-2023-earnings-call-transcript/,MGNX,0.048882,Neutral,0.062563
"MacroGenics  ( MGNX )  Reports Q4 Loss, Lags Revenue Estimates",20240307T223003,https://www.zacks.com/stock/news/2237606/macrogenics-mgnx-reports-q4-loss-lags-revenue-estimates,MGNX,0.407844,Neutral,0.137116
AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday - Advanced Micro Devices  ( NASDAQ:AMD ) ,20240304T125622,https://www.benzinga.com/news/24/03/37453217/amd-to-rally-around-16-here-are-10-top-analyst-forecasts-for-monday,MGNX,0.250386,Somewhat-Bullish,0.22965
MacroGenics to Participate in Upcoming Investor Conferences - Macrogenics  ( NASDAQ:MGNX ) ,20240301T224827,https://www.benzinga.com/pressreleases/24/03/g37434579/macrogenics-to-participate-in-upcoming-investor-conferences,MGNX,0.92528,Neutral,0.054887
MacroGenics to Participate in Upcoming Investor Conferences,20240301T224800,https://www.globenewswire.com/news-release/2024/03/01/2839116/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conferences.html,MGNX,0.936499,Neutral,0.059342
Analysts Estimate MacroGenics  ( MGNX )  to Report a Decline in Earnings: What to Look Out for,20240229T150014,https://www.zacks.com/stock/news/2233951/analysts-estimate-macrogenics-mgnx-to-report-a-decline-in-earnings-what-to-look-out-for,MGNX,0.301933,Neutral,-0.072005
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2023 Results,20240228T220000,https://www.newswire.ca/news-releases/dri-healthcare-trust-reports-fourth-quarter-and-fiscal-2023-results-808176485.html,MGNX,0.008908,Somewhat-Bullish,0.164782
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call,20240227T224500,https://www.globenewswire.com/news-release/2024/02/27/2836527/0/en/MacroGenics-Announces-Date-of-Fourth-Quarter-2023-Financial-Results-Conference-Call.html,MGNX,0.844427,Somewhat-Bullish,0.175312
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call - Macrogenics  ( NASDAQ:MGNX ) ,20240227T224500,https://www.benzinga.com/pressreleases/24/02/g37351856/macrogenics-announces-date-of-fourth-quarter-2023-financial-results-conference-call,MGNX,0.822443,Somewhat-Bullish,0.169642
"Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday - Moderna  ( NASDAQ:MRNA ) , Surgery Partners  ( NASDAQ:SGRY ) , Kosmos Energy  ( NYSE:KOS ) ",20240226T161856,https://www.benzinga.com/news/24/02/37315271/surgery-partners-posts-weak-sales-joins-kosmos-energy-moderna-and-other-big-stocks-moving-lower-on-m,MGNX,0.250386,Bearish,-0.625454
Lantheus Holdings  ( LNTH )  Q4 Earnings and Revenues Beat Estimates,20240222T133003,https://www.zacks.com/stock/news/2229947/lantheus-holdings-lnth-q4-earnings-and-revenues-beat-estimates,MGNX,0.20997,Neutral,0.0
MacroGenics to Participate in Upcoming Investor Conference - Macrogenics  ( NASDAQ:MGNX ) ,20240202T213000,https://www.benzinga.com/pressreleases/24/02/g36918349/macrogenics-to-participate-in-upcoming-investor-conference,MGNX,0.966748,Neutral,0.093912
MacroGenics to Participate in Upcoming Investor Conference,20240202T213000,https://www.globenewswire.com/news-release/2024/02/02/2823069/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conference.html,MGNX,0.961451,Neutral,0.098046
MacroGenics  ( MGNX )  Surges 6.8%: Is This an Indication of Further Gains?,20240202T121900,https://www.zacks.com/stock/news/2220037/macrogenics-mgnx-surges-68-is-this-an-indication-of-further-gains,MGNX,0.572194,Somewhat-Bullish,0.276516
"World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday - World Acceptance  ( NASDAQ:WRLD ) ",20240119T152042,https://www.benzinga.com/news/24/01/36696606/world-acceptance-posts-upbeat-earnings-joins-kaman-spirit-airlines-and-other-big-stocks-moving-highe,MGNX,0.159043,Neutral,0.0
MacroGenics to Participate in Upcoming Investor Conference - Macrogenics  ( NASDAQ:MGNX ) ,20240108T213000,https://www.benzinga.com/pressreleases/24/01/g36545433/macrogenics-to-participate-in-upcoming-investor-conference,MGNX,0.950096,Neutral,0.09767
MacroGenics to Participate in Upcoming Investor Conference,20240108T213000,https://www.globenewswire.com/news-release/2024/01/08/2805874/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conference.html,MGNX,0.940989,Neutral,0.097419
"Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday - Canaan  ( NASDAQ:CAN ) , Clear Channel Outdoor  ( NYSE:CCO ) ",20231220T151022,https://www.benzinga.com/news/23/12/36326451/toro-posts-upbeat-results-joins-clear-channel-outdoor-marathon-digital-and-other-big-stocks-moving-h,MGNX,0.344074,Somewhat-Bullish,0.292714
"Top 4 Health Care Stocks That May Crash This Month - Esperion Therapeutics  ( NASDAQ:ESPR ) , Celldex Therapeutics  ( NASDAQ:CLDX ) ",20231220T133140,https://www.benzinga.com/news/23/12/36323732/top-4-health-care-stocks-that-may-crash-this-month,MGNX,0.368773,Neutral,0.090723
"EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday - Coupang  ( NYSE:CPNG ) , EnerSys  ( NYSE:ENS ) ",20231220T125009,https://www.benzinga.com/news/23/12/36322654/enersys-to-rally-around-20-here-are-10-top-analyst-forecasts-for-wednesday,MGNX,0.247838,Bullish,0.385509
StockNews.com Lowers MacroGenics  ( NASDAQ:MGNX )  to Hold,20231116T083644,https://www.defenseworld.net/2023/11/16/stocknews-com-lowers-macrogenics-nasdaqmgnx-to-hold.html,MGNX,0.824238,Bullish,0.525638
"MacroGenics  ( NASDAQ:MGNX )  Upgraded to ""Buy"" at StockNews.com",20231109T095053,https://www.defenseworld.net/2023/11/09/macrogenics-nasdaqmgnx-upgraded-to-buy-at-stocknews-com.html,MGNX,0.775361,Bullish,0.454989
"Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday - Appian  ( NASDAQ:APPN ) , Augmedix  ( NASDAQ:AUGX ) ",20231107T155442,https://www.benzinga.com/news/23/11/35648180/datadog-tripadvisor-myriad-genetics-planet-fitness-and-other-big-stocks-moving-higher-on-tuesday,MGNX,0.146916,Somewhat-Bullish,0.228689
MacroGenics  ( MGNX )  Q3 2023 Earnings Call Transcript,20231107T061542,https://www.fool.com/earnings/call-transcripts/2023/11/07/macrogenics-mgnx-q3-2023-earnings-call-transcript/,MGNX,0.065605,Neutral,0.077308
MacroGenics to Participate in Upcoming Investor Conferences,20231102T203000,https://www.globenewswire.com/news-release/2023/11/02/2772875/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conferences.html,MGNX,0.963108,Neutral,0.119696
MacroGenics to Participate in Upcoming Investor Conferences - Macrogenics  ( NASDAQ:MGNX ) ,20231102T203000,https://www.benzinga.com/pressreleases/23/11/g35577498/macrogenics-to-participate-in-upcoming-investor-conferences,MGNX,0.856646,Neutral,0.115267
MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call,20231031T203000,https://www.globenewswire.com/news-release/2023/10/31/2770665/0/en/MacroGenics-Announces-Date-of-Third-Quarter-2023-Financial-Results-Conference-Call.html,MGNX,0.841981,Somewhat-Bullish,0.175135
MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call - Macrogenics  ( NASDAQ:MGNX ) ,20231031T203000,https://www.benzinga.com/pressreleases/23/10/g35525232/macrogenics-announces-date-of-third-quarter-2023-financial-results-conference-call,MGNX,0.822443,Somewhat-Bullish,0.169642
"MacroGenics  ( NASDAQ:MGNX )  Downgraded by StockNews.com to ""Hold""",20231018T082644,https://www.defenseworld.net/2023/10/18/macrogenics-nasdaqmgnx-downgraded-by-stocknews-com-to-hold.html,MGNX,0.702673,Somewhat-Bullish,0.310611
TRDA: 3 Biotech Stocks for Long-Term Value,20231017T171944,https://stocknews.com/news/trda-mgnx-gnft-gild-3-biotech-stocks-for-long-term-value/,MGNX,0.256839,Neutral,0.12055
CD3 Antibody Clinical Trials Market Opportunity Insight,20231012T062602,https://www.benzinga.com/pressreleases/23/10/g35212251/cd3-antibody-clinical-trials-market-opportunity-insight,MGNX,0.047278,Somewhat-Bullish,0.188605
MacroGenics  ( NASDAQ:MGNX )  Stock Rating Lowered by StockNews.com,20230929T053846,https://www.defenseworld.net/2023/09/29/macrogenics-nasdaqmgnx-stock-rating-lowered-by-stocknews-com.html,MGNX,0.725779,Bullish,0.492728
"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... - PR Newswire",20230918T091500,https://www.prnewswire.com/news-releases/breast-cancer-monoclonal-antibodies-market-to-grow-by-usd-15-billion-from-2022-to-2027-north-america-to-account-for-42-of-market-growth---technavio-301929309.html,MGNX,0.043108,Neutral,0.0
ABL Bio Taps into Synaffix ADC Technology to Accelerate Development of Bispecific ADC Products - Lonza Group  ( OTC:LZAGY ) ,20230913T070000,https://www.benzinga.com/pressreleases/23/09/n34521672/abl-bio-taps-into-synaffix-adc-technology-to-accelerate-development-of-bispecific-adc-products,MGNX,0.040484,Neutral,0.084387
SGIOY: 3 Biotech Stocks to Buy under $20,20230911T155309,https://stocknews.com/news/sgioy-mgnx-acor-3-biotech-stocks-to-buy-under-20/,MGNX,0.217834,Somewhat-Bullish,0.241459
"MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead's Nomination of a Bispecific Research Program - Macrogenics  ( NASDAQ:MGNX ) , Gilead Sciences  ( NASDAQ:GILD ) ",20230905T110000,https://www.benzinga.com/pressreleases/23/09/g34228797/macrogenics-announces-achievement-of-15-million-milestone-related-to-gileads-nomination-of-a-bispe,MGNX,0.58705,Somewhat-Bullish,0.159252
MacroGenics  ( NASDAQ:MGNX )  Stock Upgraded to Buy Rating by StockNews.com,20230905T072729,https://www.claytoncountyregister.com/news2/macrogenics-nasdaqmgnx-upgraded-to-buy-at-stocknews-com/307856/,MGNX,0.882178,Somewhat-Bullish,0.308681
MacroGenics  ( NASDAQ:MGNX )  Upgraded to Buy by StockNews.com,20230902T083844,https://www.defenseworld.net/2023/09/02/macrogenics-nasdaqmgnx-upgraded-to-buy-by-stocknews-com.html,MGNX,0.838312,Bullish,0.398181
"MRNA: Which of These 3 Biotech Stocks Are a Buy, Sell, or Hold?",20230901T174349,https://stocknews.com/news/mrna-fold-mgnx-mrk-incy-which-of-these-3-biotech-stocks-are-a-buy-sell/,MGNX,0.173958,Somewhat-Bullish,0.158036
MacroGenics to Participate in Upcoming Investor Conferences,20230831T203000,https://www.globenewswire.com/news-release/2023/08/31/2735713/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conferences.html,MGNX,0.950503,Neutral,0.084865
MacroGenics to Participate in Upcoming Investor Conferences - Macrogenics  ( NASDAQ:MGNX ) ,20230831T203000,https://www.benzinga.com/pressreleases/23/08/g34157355/macrogenics-to-participate-in-upcoming-investor-conferences,MGNX,0.939207,Neutral,0.084535
3 Under-the-Radar Biotech Stocks to Buy in 2023,20230819T114000,https://www.fool.com/investing/2023/08/19/3-under-the-radar-biotech-stocks-to-buy-in-2023/,MGNX,0.286082,Neutral,0.084344
MacroGenics'  ( MGNX )  Shares Jump 19% in One Week: Here's Why,20230814T151900,https://www.zacks.com/stock/news/2136295/macrogenics-mgnx-shares-jump-19-in-one-week-heres-why,MGNX,0.764396,Somewhat-Bullish,0.291637
Why Shares of MacroGenics Are Jumping Thursday,20230810T163341,https://www.fool.com/investing/2023/08/10/why-shares-of-macrogenics-are-jumping-thursday/,MGNX,0.846873,Neutral,0.147253
"Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday - Alarm.com Holdings  ( NASDAQ:ALRM ) , Applied Industrial  ( NYSE:AIT ) ",20230810T143943,https://www.benzinga.com/news/23/08/33711133/alibaba-illumina-cyberark-software-and-other-big-stocks-moving-higher-on-thursday,MGNX,0.149656,Somewhat-Bullish,0.285522
MacroGenics  ( MGNX )  Q2 2023 Earnings Call Transcript,20230810T033023,https://www.fool.com/earnings/call-transcripts/2023/08/09/macrogenics-mgnx-q2-2023-earnings-call-transcript/,MGNX,0.072479,Neutral,0.058581
"MacroGenics  ( MGNX )  Reports Q2 Loss, Misses Revenue Estimates",20230809T215014,https://www.zacks.com/stock/news/2134589/macrogenics-mgnx-reports-q2-loss-misses-revenue-estimates,MGNX,0.400265,Neutral,0.046619
MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results - Macrogenics  ( NASDAQ:MGNX ) ,20230809T200100,https://www.benzinga.com/pressreleases/23/08/g33677875/macrogenics-provides-update-on-corporate-progress-and-second-quarter-2023-financial-results,MGNX,0.531326,Somewhat-Bullish,0.232465
MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call,20230731T213500,https://www.globenewswire.com/news-release/2023/07/31/2715371/0/en/MacroGenics-Announces-Date-of-Second-Quarter-2023-Financial-Results-Conference-Call.html,MGNX,0.841981,Somewhat-Bullish,0.171164
MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call - Macrogenics  ( NASDAQ:MGNX ) ,20230731T213500,https://www.benzinga.com/pressreleases/23/07/g33481632/macrogenics-announces-date-of-second-quarter-2023-financial-results-conference-call,MGNX,0.820009,Somewhat-Bullish,0.169503
"Cutaneous Melanoma Market is Predicted to Exhibit Remarkable Growth, Predicts DelveInsight | Key Companies - Merck, Amgen, Anaveon, Eisai, Regeneron, BMS, AstraZeneca, Seagen, Novartis, Eli Lilly and Company",20230724T210100,https://www.prnewswire.com/news-releases/cutaneous-melanoma-market-is-predicted-to-exhibit-remarkable-growth-predicts-delveinsight--key-companies---merck-amgen-anaveon-eisai-regeneron-bms-astrazeneca-seagen-novartis-eli-lilly-and-company-301883725.html,MGNX,0.02692,Neutral,0.029117
Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,20230703T210100,https://www.prnewswire.com/news-releases/bispecific-antibody-clinical-trial-pipeline-appears-robust-with-250-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-301868673.html,MGNX,0.081483,Neutral,0.144952
AdaptHealth Corp.  ( AHCO )  Soars 19.6%: Is Further Upside Left in the Stock?,20230628T121200,https://www.zacks.com/stock/news/2114042/adapthealth-corp-ahco-soars-196-is-further-upside-left-in-the-stock,MGNX,0.524949,Neutral,-0.086293
Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain,20230626T210100,https://www.prnewswire.com/news-releases/antibody-drug-conjugates-clinical-trial-pipeline-experiences-momentum-delveinsight-estimates-a-diverse-pipeline-comprising-180-companies-working-in-the-domain-301862784.html,MGNX,0.041791,Neutral,0.070986
MacroGenics  ( NASDAQ:MGNX )  Downgraded by StockNews.com to Hold,20230621T051847,https://www.defenseworld.net/2023/06/21/macrogenics-nasdaqmgnx-downgraded-by-stocknews-com-to-hold.html,MGNX,0.95593,Bullish,0.350449
MacroGenics  ( NASDAQ:MGNX )  Downgraded to Hold at StockNews.com,20230610T081444,https://www.defenseworld.net/2023/06/10/macrogenics-nasdaqmgnx-downgraded-to-hold-at-stocknews-com.html,MGNX,0.898236,Bullish,0.404555
Here's Why You Should Add ImmunoGen  ( IMGN )  to Your Portfolio Now,20230519T150900,https://www.zacks.com/stock/news/2097447/heres-why-you-should-add-immunogen-imgn-to-your-portfolio-now,MGNX,0.073098,Neutral,-0.028545
MacroGenics  ( MGNX )  Q1 2023 Earnings Call Transcript,20230510T043040,https://www.fool.com/earnings/call-transcripts/2023/05/10/macrogenics-mgnx-q1-2023-earnings-call-transcript/,MGNX,0.056518,Neutral,0.054992
"MacroGenics  ( MGNX )  Reports Q1 Loss, Misses Revenue Estimates",20230509T212511,https://www.zacks.com/stock/news/2092716/macrogenics-mgnx-reports-q1-loss-misses-revenue-estimates,MGNX,0.405651,Neutral,0.142051
MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call,20230504T203000,https://www.globenewswire.com/news-release/2023/05/04/2662130/0/en/MacroGenics-Announces-Date-of-First-Quarter-2023-Financial-Results-Conference-Call.html,MGNX,0.844427,Somewhat-Bullish,0.175379
MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call - Macrogenics  ( NASDAQ:MGNX ) ,20230504T203000,https://www.benzinga.com/pressreleases/23/05/g32225934/macrogenics-announces-date-of-first-quarter-2023-financial-results-conference-call,MGNX,0.824879,Somewhat-Bullish,0.173864
"ImmunoGen  ( IMGN )  Q1 Earnings Beat, Elahere Uptake Encouraging",20230501T150000,https://www.zacks.com/stock/news/2087582/immunogen-imgn-q1-earnings-beat-elahere-uptake-encouraging,MGNX,0.036869,Neutral,0.009837
MacroGenics  ( MGNX )  to Report Q1 Results: Wall Street Expects Earnings Growth,20230425T140144,https://www.zacks.com/stock/news/2084256/macrogenics-mgnx-to-report-q1-results-wall-street-expects-earnings-growth,MGNX,0.3038,Somewhat-Bullish,0.223664
MacroGenics to Participate in Upcoming Investor Conferences,20230424T221500,https://www.globenewswire.com/news-release/2023/04/24/2653431/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conferences.html,MGNX,0.947069,Neutral,0.109883
MacroGenics to Participate in Upcoming Investor Conferences - Macrogenics  ( NASDAQ:MGNX ) ,20230424T221500,https://www.benzinga.com/pressreleases/23/04/g31973707/macrogenics-to-participate-in-upcoming-investor-conferences,MGNX,0.936499,Neutral,0.101115
EXEL: 3 Biotech Stocks Losing Momentum as March Ends,20230329T141736,https://stocknews.com/news/exel-mgnx-pbyi-incy-3-biotech-stocks-losing-momentum-as-march-ends/,MGNX,0.270773,Somewhat-Bullish,0.208644
Incyte  ( INCY )  Receives FDA Approval for Skin Cancer Treatment,20230323T161400,https://www.zacks.com/stock/news/2069786/incyte-incy-receives-fda-approval-for-skin-cancer-treatment,MGNX,0.075874,Neutral,0.0
"Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval - Incyte  ( NASDAQ:INCY ) ",20230323T113919,https://www.benzinga.com/general/biotech/23/03/31471634/incyte-would-now-compete-with-merck-pfizer-as-its-skin-cancer-treatment-scores-fda-accelerated-ap,MGNX,0.271274,Neutral,0.0
US FDA grants accelerated approval for Incyte's skin cancer therapy,20230322T174600,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-incytes-therapy-skin-cancer-2023-03-22/,MGNX,0.282234,Neutral,0.0
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™  ( retifanlimab-dlwr ) ,20230322T172200,https://www.globenewswire.com/news-release/2023/03/22/2632605/0/en/MacroGenics-Earns-15-Million-Milestone-Following-U-S-FDA-Approval-of-ZYNYZ-retifanlimab-dlwr.html,MGNX,0.568435,Neutral,0.147012
GILD: 3 Stocks to Buy Now for More Potential Upside,20230322T163842,https://stocknews.com/news/gild-teva-mgnx-3-stocks-to-buy-now-for-more-potential-upside/,MGNX,0.19117,Neutral,-0.025808
Why MacroGenics Stock Inched Higher on Monday,20230320T225953,https://www.fool.com/investing/2023/03/20/why-macrogenics-stock-inched-higher-on-monday/,MGNX,0.690822,Somewhat-Bullish,0.201804
Why MacroGenics Stock Tumbled Today,20230317T221537,https://www.fool.com/investing/2023/03/17/why-macrogenics-stock-tumbled-today/,MGNX,0.733479,Neutral,0.063375
Why Shares of MacroGenics Climbed Thursday,20230316T161729,https://www.fool.com/investing/2023/03/16/why-shares-of-macrogenics-climbed-thursday/,MGNX,0.597963,Somewhat-Bullish,0.162105
"Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday - Certara  ( NASDAQ:CERT ) , Academy Sports  ( NASDAQ:ASO ) ",20230316T141844,https://www.benzinga.com/news/23/03/31381262/signet-jewelers-designer-brands-academy-sports-and-outdoors-and-other-big-stocks-moving-higher-on-th,MGNX,0.263942,Bullish,0.416957
MacroGenics  ( MGNX )  Q4 2022 Earnings Call Transcript,20230316T030035,https://www.fool.com/earnings/call-transcripts/2023/03/15/macrogenics-mgnx-q4-2022-earnings-call-transcript/,MGNX,0.063124,Neutral,0.092118
MacroGenics  ( MGNX )  Surpasses Q4 Earnings Estimates,20230315T213504,https://www.zacks.com/stock/news/2066364/macrogenics-mgnx-surpasses-q4-earnings-estimates,MGNX,0.402403,Neutral,0.063392
Provention  ( PRVB )  Skyrockets 260% on Buyout Offer From Sanofi,20230314T163200,https://www.zacks.com/stock/news/2065615/provention-prvb-skyrockets-260-on-buyout-offer-from-sanofi,MGNX,0.32478,Somewhat-Bullish,0.271931
Synaffix Announces Expansion of ADC Collaboration with MacroGenics,20230314T121400,https://www.prnewswire.com/news-releases/synaffix-announces-expansion-of-adc-collaboration-with-macrogenics-301771459.html,MGNX,0.589946,Somewhat-Bullish,0.288175
"Illumina, Seagen And Other Big Stocks Moving Higher On Monday - Agenus  ( NASDAQ:AGEN ) , First Majestic Silver  ( NYSE:AG ) ",20230313T145550,https://www.benzinga.com/news/23/03/31322709/illumina-seagen-and-other-big-stocks-moving-higher-on-monday,MGNX,0.162802,Neutral,0.0
Why Shares of MacroGenics Jumped Thursday,20230309T205900,https://www.fool.com/investing/2023/03/09/why-shares-of-macrogenics-jumped-thursday/,MGNX,0.754041,Bullish,0.429893
"General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday - Asana  ( NYSE:ASAN ) , Assertio Holdings  ( NASDAQ:ASRT ) ",20230309T152241,https://www.benzinga.com/news/23/03/31279291/general-electric-build-a-bear-workshop-asana-and-other-big-stocks-moving-higher-on-thursday,MGNX,0.313484,Somewhat-Bullish,0.310825
MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million,20230308T223600,https://www.globenewswire.com/news-release/2023/03/08/2623580/0/en/MacroGenics-Announces-Sale-of-TZIELD-Royalty-Interest-for-up-to-200-Million.html,MGNX,0.507331,Somewhat-Bullish,0.159376
"Evolus, Inc.  ( EOLS )  Reports Q4 Loss, Tops Revenue Estimates",20230308T223504,https://www.zacks.com/stock/news/2063171/evolus-inc-eols-reports-q4-loss-tops-revenue-estimates,MGNX,0.212425,Neutral,0.0
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of TZIELD™  ( teplizumab-mzwv )  and Updates Long-Term Cash Receipts Outlook,20230308T223000,https://www.newswire.ca/news-releases/dri-healthcare-trust-announces-acquisition-of-a-royalty-interest-in-the-worldwide-sales-of-tzield-tm-teplizumab-mzwv-and-updates-long-term-cash-receipts-outlook-870382808.html,MGNX,0.091046,Somewhat-Bullish,0.161886
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call,20230307T230000,https://www.globenewswire.com/news-release/2023/03/07/2622612/0/en/MacroGenics-Announces-Date-of-Fourth-Quarter-2022-Financial-Results-Conference-Call.html,MGNX,0.849318,Somewhat-Bullish,0.175731
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call - Macrogenics  ( NASDAQ:MGNX ) ,20230307T230000,https://www.benzinga.com/pressreleases/23/03/g31249044/macrogenics-announces-date-of-fourth-quarter-2022-financial-results-conference-call,MGNX,0.827318,Somewhat-Bullish,0.174048
MacroGenics to Participate in Upcoming Investor Conferences,20230302T213000,https://www.globenewswire.com/news-release/2023/03/02/2619879/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conferences.html,MGNX,0.951851,Neutral,0.131192
MacroGenics to Participate in Upcoming Investor Conferences - Macrogenics  ( NASDAQ:MGNX ) ,20230302T213000,https://www.benzinga.com/pressreleases/23/03/g31182657/macrogenics-to-participate-in-upcoming-investor-conferences,MGNX,0.940667,Neutral,0.130693
"NanoString Technologies  ( NSTG )  Reports Q4 Loss, Tops Revenue Estimates",20230228T221507,https://www.zacks.com/stock/news/2060010/nanostring-technologies-nstg-reports-q4-loss-tops-revenue-estimates,MGNX,0.211191,Neutral,0.0
Strength Seen in MacroGenics  ( MGNX ) : Can Its 25.7% Jump Turn into More Strength?,20230220T145600,https://www.zacks.com/stock/news/2056380/strength-seen-in-macrogenics-mgnx-can-its-257-jump-turn-into-more-strength,MGNX,0.627119,Somewhat-Bullish,0.315608
"AutoNation, HubSpot, AMC Networks And Other Big Stocks Moving Higher On Friday - AutoNation  ( NYSE:AN ) , AMC Networks  ( NASDAQ:AMCX ) ",20230217T150719,https://www.benzinga.com/news/23/02/30960969/autonation-hubspot-amc-networks-and-other-big-stocks-moving-higher-on-friday,MGNX,0.339356,Somewhat-Bullish,0.235875
"Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying - Macrogenics  ( NASDAQ:MGNX ) , Bluerock Homes Trust  ( AMEX:BHM ) ",20230217T125812,https://www.benzinga.com/trading-ideas/long-ideas/23/02/30958638/around-11m-bet-on-insight-enterprises-check-out-these-4-stocks-insiders-are-buying,MGNX,0.405215,Somewhat-Bullish,0.189892
MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients - Macrogenics  ( NASDAQ:MGNX ) ,20230214T150127,https://www.benzinga.com/general/biotech/23/02/30898929/macrogenics-posts-interim-data-from-lorigerlimab-study-in-prostate-cancer-patients,MGNX,0.612033,Somewhat-Bullish,0.175339
MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium,20230213T222000,https://www.globenewswire.com/news-release/2023/02/13/2607171/0/en/MacroGenics-Announces-Preliminary-Clinical-Results-from-Single-Arm-Study-of-Lorigerlimab-in-Patients-with-Metastatic-Castration-Resistant-Prostate-Cancer-to-be-Presented-at-ASCO-Ge.html,MGNX,0.316507,Neutral,0.041611
MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium - Macrogenics  ( NASDAQ:MGNX ) ,20230213T222000,https://www.benzinga.com/pressreleases/23/02/g30890103/macrogenics-announces-preliminary-clinical-results-from-single-arm-study-of-lorigerlimab-in-patien,MGNX,0.309215,Neutral,0.04083
MacroGenics to Participate in Upcoming Investor Conferences,20230206T213000,https://www.globenewswire.com/news-release/2023/02/06/2602533/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conferences.html,MGNX,0.947763,Neutral,0.147695
MacroGenics to Participate in Upcoming Investor Conferences - Macrogenics  ( NASDAQ:MGNX ) ,20230206T213000,https://www.benzinga.com/pressreleases/23/02/g30743057/macrogenics-to-participate-in-upcoming-investor-conferences,MGNX,0.936251,Neutral,0.14296
"Chong Kun Dang Pharm Licenses Synaffix ADC Technology, Adds Novel ADC Candidate to Oncology Pipeline",20230206T080000,https://www.prnewswire.com/news-releases/chong-kun-dang-pharm-licenses-synaffix-adc-technology-adds-novel-adc-candidate-to-oncology-pipeline-301738575.html,MGNX,0.049526,Neutral,0.111163
Gilead Sciences  ( GILD )  Q4 2022 Earnings Call Transcript,20230203T020023,https://www.fool.com/earnings/call-transcripts/2023/02/02/gilead-sciences-gild-q4-2022-earnings-call-transcr/,MGNX,0.004354,Neutral,-0.030099
"With 14.1% CAGR, Monoclonal Antibody Therapy Market Size Worth USD 451.89 Billion by 2028",20230130T105418,https://www.benzinga.com/pressreleases/23/01/g30618366/with-14-1-cagr-monoclonal-antibody-therapy-market-size-worth-usd-451-89-billion-by-2028,MGNX,0.071892,Neutral,0.089019
SurModics  ( SRDX )  Surges 6.1%: Is This an Indication of Further Gains?,20230124T125700,https://www.zacks.com/stock/news/2043113/surmodics-srdx-surges-61-is-this-an-indication-of-further-gains,MGNX,0.482078,Neutral,0.0
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday,20230119T125718,https://www.benzinga.com/news/23/01/30480523/tesla-to-rally-around-138-here-are-10-other-analyst-forecasts-for-thursday,MGNX,0.276909,Somewhat-Bullish,0.216265
MacroGenics  ( MGNX )  Stock Sinks As Market Gains: What You Should Know,20230106T231521,https://www.zacks.com/stock/news/2036503/macrogenics-mgnx-stock-sinks-as-market-gains-what-you-should-know,MGNX,0.63188,Somewhat-Bullish,0.314816
Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs,20230105T140000,https://www.prnewswire.com/news-releases/synaffix-enters-license-agreement-with-amgen-to-build-next-generation-adcs-301714411.html,MGNX,0.059636,Somewhat-Bullish,0.190027
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference,20230104T225000,https://www.globenewswire.com/news-release/2023/01/04/2583327/0/en/MacroGenics-to-Present-at-the-41st-Annual-J-P-Morgan-Healthcare-Conference.html,MGNX,0.967875,Neutral,0.106904
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Macrogenics  ( NASDAQ:MGNX ) ,20230104T225000,https://www.benzinga.com/pressreleases/23/01/g30286213/macrogenics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference,MGNX,0.947917,Neutral,0.106222
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors,20230104T213000,https://www.globenewswire.com/news-release/2023/01/04/2583300/0/en/MacroGenics-Announces-Appointment-of-Dr-Margaret-Liu-and-Meenu-Chhabra-Karson-to-Board-of-Directors.html,MGNX,0.439026,Neutral,0.122696
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors - Macrogenics  ( NASDAQ:MGNX ) ,20230104T213000,https://www.benzinga.com/pressreleases/23/01/g30283535/macrogenics-announces-appointment-of-dr-margaret-liu-and-meenu-chhabra-karson-to-board-of-director,MGNX,0.435011,Neutral,0.119033
Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate  ( ADC )  Program,20230104T191500,https://www.benzinga.com/pressreleases/23/01/n30280537/hummingbird-bioscience-and-synaffix-enter-license-agreement-to-develop-a-next-generation-antibody-,MGNX,0.044469,Neutral,0.110091
Another Award for Synaffix: 'Business Development Team of Year' at the Scrip Awards,20221213T080000,https://www.prnewswire.com/news-releases/another-award-for-synaffix--business-development-team-of-year-at-the-scrip-awards-301700641.html,MGNX,0.102888,Somewhat-Bullish,0.180641
Can MacroGenics  ( MGNX )  Climb 74% to Reach the Level Wall Street Analysts Expect?,20221205T145514,https://www.zacks.com/stock/news/2025372/can-macrogenics-mgnx-climb-74-to-reach-the-level-wall-street-analysts-expect,MGNX,0.287537,Bullish,0.360009
Buy These 3 Top Stocks for Solid Earnings Acceleration,20221205T122500,https://www.zacks.com/stock/news/2025176/buy-these-3-top-stocks-for-solid-earnings-acceleration,MGNX,0.150592,Somewhat-Bullish,0.217947
MacroGenics  ( MGNX )  Recently Broke Out Above the 20-Day Moving Average,20221202T143504,https://www.zacks.com/stock/news/2024760/macrogenics-mgnx-recently-broke-out-above-the-20-day-moving-average,MGNX,0.702434,Bullish,0.545592
NRP: The 3 Best Dividend Stocks to Purchase Right Now,20221130T154603,https://stocknews.com/news/nrp-spok-gild-the-3-best-dividend-stocks-to-purchase-right-now/,MGNX,0.069294,Somewhat-Bullish,0.173888
Here's How to Find Cheap Stocks Under $10 to Buy for December,20221129T175700,https://www.zacks.com/commentary/2023363/heres-how-to-find-cheap-stocks-under-10-to-buy-for-december,MGNX,0.235062,Neutral,-0.06763
"$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying - GoHealth  ( NASDAQ:GOCO ) , IAC  ( NASDAQ:IAC ) ",20221128T111401,https://www.benzinga.com/trading-ideas/long-ideas/22/11/29866981/5-million-bet-on-iac-check-out-these-3-stocks-insiders-are-buying,MGNX,0.577527,Somewhat-Bullish,0.169675
"Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56% - Arvinas  ( NASDAQ:ARVN ) , American Eagle Outfitters  ( NYSE:AEO ) ",20221123T155641,https://www.benzinga.com/news/22/11/29841487/baidu-to-180-plus-this-analyst-cuts-pt-on-macrogenics-by-56,MGNX,0.721785,Bullish,0.448913
"Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box - Analog Devices  ( NASDAQ:ADI ) , Arvinas  ( NASDAQ:ARVN ) ",20221123T135848,https://www.benzinga.com/news/22/11/29838906/burlington-stores-to-surge-over-21-plus-wedbush-slashes-pt-on-jack-in-the-box,MGNX,0.521465,Somewhat-Bullish,0.348426
Why Gilead's Cancer Biz Is Driving The Stock To A Fever Pitch,20221123T124500,https://www.investors.com/news/technology/gild-stock-surges-why-gilead-sees-its-oncology-business-as-a-force-to-be-reckoned-with/,MGNX,0.064623,Neutral,0.080067
"Dow Jumps Over 300 Points; S&P 500 Rises 1% - American Res  ( NASDAQ:AREC ) , Agora  ( NASDAQ:API ) ",20221122T192313,https://www.benzinga.com/news/earnings/22/11/29829239/dow-jumps-over-300-points-s-p-500-rises-1,MGNX,0.143415,Neutral,0.121965
"Crude Oil Surges 2%; Best Buy Posts Upbeat Earnings - Best Buy Co  ( NYSE:BBY ) , Agora  ( NASDAQ:API ) ",20221122T174032,https://www.benzinga.com/news/earnings/22/11/29827589/crude-oil-surges-2-best-buy-posts-upbeat-earnings,MGNX,0.146025,Neutral,0.123314
Why Shares of MacroGenics Were Dropping Tuesday,20221122T165558,https://www.fool.com/investing/2022/11/22/why-shares-of-macrogenics-were-dropping-tuesday/,MGNX,0.815149,Neutral,0.06484
"US Stocks Open Higher As Dow Surges 250 Points - AGBA Group Holding  ( NASDAQ:AGBA ) , Aenza SAA  ( NYSE:AENZ ) ",20221122T153511,https://www.benzinga.com/news/earnings/22/11/29825180/us-stocks-open-higher-as-dow-surges-250-points,MGNX,0.169081,Neutral,0.135734
AMGN: 2 Biotech Stocks to Buy in November and 1 to Sell,20221121T195854,https://stocknews.com/news/amgn-gild-dna-2-biotech-stocks-to-buy-in-november-and-1-to/,MGNX,0.077719,Somewhat-Bullish,0.175686
Provention  ( PRVB )  Gets FDA Nod for Drug That Delays T1D Onset,20221118T151500,https://www.zacks.com/stock/news/2019947/provention-prvb-gets-fda-nod-for-drug-that-delays-t1d-onset,MGNX,0.377142,Bullish,0.39953
Why Provention Bio  ( PRVB )  Shares Are Trading Higher Premarket Today? - Provention Bio  ( NASDAQ:PRVB ) ,20221118T113942,https://www.benzinga.com/general/biotech/22/11/29780945/first-drug-that-can-delay-onset-of-type-1-diabetes-gets-fda-approval-after-multiple-regulatory-hu,MGNX,0.392948,Bullish,0.620169
"Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session - Applied Materials  ( NASDAQ:AMAT ) , Foot Locker  ( NYSE:FL ) ",20221118T111100,https://www.benzinga.com/news/22/11/29781391/gap-palo-alto-networks-and-some-other-big-stocks-moving-higher-in-todays-pre-market-session,MGNX,0.364275,Bullish,0.414264
U.S. FDA greenlights Provention Bio's diabetes drug,20221117T233200,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-greenlights-provention-bios-diabetes-drug-2022-11-17/,MGNX,0.119235,Neutral,0.00576
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab,20221117T231000,https://www.globenewswire.com/news-release/2022/11/17/2558767/0/en/MacroGenics-Earns-60-Million-Milestone-with-U-S-FDA-Approval-of-Teplizumab.html,MGNX,0.641573,Somewhat-Bullish,0.233893
MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab - Macrogenics  ( NASDAQ:MGNX ) ,20221117T231000,https://www.benzinga.com/pressreleases/22/11/g29777756/macrogenics-earns-60-million-milestone-with-u-s-fda-approval-of-teplizumab,MGNX,0.629016,Somewhat-Bullish,0.228188
Wall Street Analysts Believe MacroGenics  ( MGNX )  Could Rally 123%: Here's is How to Trade,20221117T145512,https://www.zacks.com/stock/news/2019411/wall-street-analysts-believe-macrogenics-mgnx-could-rally-123-heres-is-how-to-trade,MGNX,0.286193,Bullish,0.368137
5 Best Stocks to Invest in for Solid Earnings Acceleration,20221117T121600,https://www.zacks.com/stock/news/2019238/5-best-stocks-to-invest-in-for-solid-earnings-acceleration,MGNX,0.136629,Somewhat-Bullish,0.206529
Why MacroGenics Stock Crushed the Market on Monday,20221114T233131,https://www.fool.com/investing/2022/11/14/why-macrogenics-stock-crushed-the-market-on-monday/,MGNX,0.67628,Bullish,0.540038
"MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences - Exact Sciences  ( NASDAQ:EXAS ) , AirSculpt Technologies  ( NASDAQ:AIRS ) ",20221114T154812,https://www.benzinga.com/news/22/11/29704639/macrogenics-to-surge-138-plus-this-analyst-sees-50-for-exact-sciences,MGNX,0.682689,Bullish,0.810625
"360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session - Agenus  ( NASDAQ:AGEN ) , ATAI Life Sciences  ( NASDAQ:ATAI ) ",20221114T125539,https://www.benzinga.com/news/22/11/29698616/360-digitech-hutchmed-and-some-other-big-stocks-moving-higher-in-todays-pre-market-session,MGNX,0.294093,Bullish,0.486221
Blue Star  ( NASDAQ: BSFC )  Insiders Are Buying Stock - Blue Star Foods  ( NASDAQ:BSFC ) ,20221111T134149,https://www.benzinga.com/news/22/11/29680107/blue-star-nasdaq-bsfc-insiders-are-buying-stock,MGNX,0.175859,Neutral,0.113913
Why MacroGenics Stock Popped Again Today,20221107T234043,https://www.fool.com/investing/2022/11/07/why-macrogenics-stock-popped-again-today/,MGNX,0.519739,Bullish,0.52744
"ImmunoGen  ( IMGN )  Q3 Loss Wider, Sales Beat, '22 View Up",20221107T190700,https://www.zacks.com/stock/news/2014969/immunogen-imgn-q3-loss-wider-sales-beat-22-view-up,MGNX,0.035608,Neutral,-0.084902
"Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday - Alcoa  ( NYSE:AA ) , Adient  ( NYSE:ADNT ) ",20221107T080741,https://www.benzinga.com/news/22/11/29586663/why-mediaalpha-shares-jumped-around-30-here-are-112-biggest-movers-from-friday,MGNX,0.03443,Somewhat-Bullish,0.203838
Why MacroGenics Stock Blasted Higher Today,20221104T225154,https://www.fool.com/investing/2022/11/04/why-macrogenics-stock-blasted-higher-today/,MGNX,0.695767,Bullish,0.407134
MacroGenics  ( MGNX )  Q3 2022 Earnings Call Transcript,20221104T033028,https://www.fool.com/earnings/call-transcripts/2022/11/03/macrogenics-mgnx-q3-2022-earnings-call-transcript/,MGNX,0.141854,Neutral,0.134549
Gilead and Kite Oncology Demonstrate Transformative Impact of Cell Therapy and Promise of Blood Cancer Portfolio at ASH 2022,20221103T132124,https://investingnews.com/gilead-and-kite-oncology-demonstrate-transformative-impact-of-cell-therapy-and-promise-of-blood-cancer-portfolio-at-ash-2022/,MGNX,0.024421,Somewhat-Bullish,0.152776
Provention Bio Reports Third Quarter 2022 Financial Results and Provides Business Update,20221103T110000,https://www.prnewswire.com/news-releases/provention-bio-reports-third-quarter-2022-financial-results-and-provides-business-update-301667012.html,MGNX,0.015747,Somewhat-Bullish,0.211528
MacroGenics to Participate in Upcoming Investor Conferences,20221102T203000,https://www.globenewswire.com/news-release/2022/11/02/2547109/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conferences.html,MGNX,0.972119,Neutral,0.076764
MacroGenics to Participate in Upcoming Investor Conferences - Macrogenics  ( NASDAQ:MGNX ) ,20221102T203000,https://www.benzinga.com/pressreleases/22/11/g29533357/macrogenics-to-participate-in-upcoming-investor-conferences,MGNX,0.965189,Neutral,0.072337
"Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know - iShares Biotechnology ETF  ( NASDAQ:IBB ) , BondBloxx ETF Trust BondBloxx BB-Rated USD High Yield Corporate Bond ETF  ( ARCA:XBB ) ",20221101T200154,https://www.benzinga.com/general/biotech/22/11/29508633/provention-bios-second-try-apelliss-eye-disorder-drug-review-3-adcom-verdicts-and-more-novembers-,MGNX,0.09402,Neutral,-0.023179
Wall Street Analysts See a 279% Upside in MacroGenics  ( MGNX ) : Can the Stock Really Move This High?,20221101T135511,https://www.zacks.com/stock/news/2011778/wall-street-analysts-see-a-279-upside-in-macrogenics-mgnx-can-the-stock-really-move-this-high,MGNX,0.287537,Bullish,0.360009
Gilead Sciences  ( GILD )  Q3 2022 Earnings Call Transcript,20221028T020055,https://www.fool.com/earnings/call-transcripts/2022/10/27/gilead-sciences-gild-q3-2022-earnings-call-transcr/,MGNX,0.012913,Neutral,0.078743
MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call,20221026T203000,https://www.globenewswire.com/news-release/2022/10/26/2542286/0/en/MacroGenics-Announces-Date-of-Third-Quarter-2022-Financial-Results-Conference-Call.html,MGNX,0.846873,Somewhat-Bullish,0.175556
MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call - Macrogenics  ( NASDAQ:MGNX ) ,20221026T203000,https://www.benzinga.com/pressreleases/22/10/g29425781/macrogenics-announces-date-of-third-quarter-2022-financial-results-conference-call,MGNX,0.824879,Somewhat-Bullish,0.173864
Analysts Estimate Zimmer Biomet  ( ZBH )  to Report a Decline in Earnings: What to Look Out for,20221026T140155,https://www.zacks.com/stock/news/1997669/analysts-estimate-zimmer-biomet-zbh-to-report-a-decline-in-earnings-what-to-look-out-for,MGNX,0.175539,Neutral,0.024065
"$7.5 Million Bet On Local Bounti? Check Out These 3 Penny Stocks Insiders Are Buying - Macrogenics  ( NASDAQ:MGNX ) , Local Bounti  ( NYSE:LOCL ) ",20221026T133757,https://www.benzinga.com/trading-ideas/long-ideas/22/10/29417003/7-5-million-bet-on-local-bounti-check-out-these-3-penny-stocks-insiders-are-buying,MGNX,0.533481,Somewhat-Bullish,0.315863
MacroGenics  ( MGNX )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?,20221025T140146,https://www.zacks.com/stock/news/1996817/macrogenics-mgnx-expected-to-beat-earnings-estimates-can-the-stock-move-higher,MGNX,0.259727,Somewhat-Bullish,0.195599
"Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday - Amprius Technologies  ( NYSE:AMPX ) , ALFI  ( NASDAQ:ALF ) ",20221024T093702,https://www.benzinga.com/news/22/10/29374553/why-huntington-bancshares-shares-surged-around-10-here-are-72-biggest-movers-from-friday,MGNX,0.062761,Neutral,0.0
Gilead  ( GILD )  Inks Deal for Gene Platform in Blood Cancers,20221021T162700,https://www.zacks.com/stock/news/1995823/gilead-gild-inks-deal-for-gene-platform-in-blood-cancers,MGNX,0.306007,Somewhat-Bullish,0.255828
GILD: 2 No-Brainer Biotech Stocks to Buy Right Now and 1 to Sell,20221018T203326,https://stocknews.com/news/gild-vrtx-rlmd-2-no-brainer-biotech-stocks-to-buy-right-now-and-1/,MGNX,0.08183,Somewhat-Bullish,0.182033
Gilead's  ( GILD )  Yescarta Gets EC Nod for New Cancer Indication,20221018T164400,https://www.zacks.com/stock/news/1993697/gileads-gild-yescarta-gets-ec-nod-for-new-cancer-indication,MGNX,0.319725,Somewhat-Bullish,0.332027
Europe Approves First CAR T-Cell Therapy For B-Cell Lymphoma In 30 Years to Improve Upon Standard of Care - Gilead Sciences  ( NASDAQ:GILD ) ,20221018T132607,https://www.benzinga.com/general/biotech/22/10/29306003/europe-approves-first-car-t-cell-therapy-for-b-cell-lymphoma-in-30-years-to-improve-upon-standard,MGNX,0.181137,Somewhat-Bearish,-0.195697
Why MacroGenics  ( MGNX )  Shares Are Trading Higher Today - Macrogenics  ( NASDAQ:MGNX ) ,20221017T131503,https://www.benzinga.com/general/biotech/22/10/29286223/macrogenics-shares-jump-on-gilead-licensing-pact-for-blood-cancer-candidates,MGNX,0.947069,Somewhat-Bullish,0.16079
Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies - Investing News Network,20221017T114942,https://investingnews.com/gilead-and-macrogenics-announce-oncology-collaboration-to-develop-bispecific-antibodies/,MGNX,0.638259,Neutral,0.084437
Why MacroGenics Stock Sank Today,20220912T231457,https://www.fool.com/investing/2022/09/12/why-macrogenetics-stock-sank-today/,MGNX,0.743681,Neutral,-0.125961
"Adobe  ( NASDAQ:ADBE ) , American Intl Gr  ( NYSE:AIG )  - This Analyst Slashes PT On Meta Platforms, Plus Mizuho Predicts $440 For Adobe",20220912T123351,https://www.benzinga.com/news/22/09/28828293/this-analyst-slashes-pt-on-meta-platforms-plus-mizuho-predicts-440-for-adobe,MGNX,0.441059,Somewhat-Bearish,-0.307828
MacroGenics to Participate in Upcoming Investor Conferences,20220902T110000,https://www.globenewswire.com/news-release/2022/09/02/2509175/0/en/MacroGenics-to-Participate-in-Upcoming-Investor-Conferences.html,MGNX,0.947069,Neutral,0.105708
MacroGenics  ( MGNX )  - MacroGenics to Participate in Upcoming Investor Conferences,20220902T110000,https://www.benzinga.com/pressreleases/22/09/g28731496/macrogenics-to-participate-in-upcoming-investor-conferences,MGNX,0.929556,Neutral,0.10508
"I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2022",20220830T100000,https://www.prnewswire.com/news-releases/i-mab-provides-business-and-corporate-updates-and-reports-financial-results-for-the-six-months-ended-june-30-2022-301614531.html,MGNX,0.022898,Neutral,0.00281
"SVB Leerink Slashes Price Target On This Stock By Over 73%, Plus This Analyst Predicts $56 For Toll Brothers",20220829T115421,https://www.benzinga.com/news/22/08/28665881/svb-leerink-slashes-price-target-on-this-stock-by-over-73-plus-this-analyst-predicts-56-for-toll-bro,MGNX,0.2306,Somewhat-Bullish,0.170883
"Bright Peak Therapeutics Announces the Appointment of Cancer Immunotherapy Leader Jon Wigginton, M.D., as President of Research and Development",20220822T110000,https://www.benzinga.com/pressreleases/22/08/g28581547/bright-peak-therapeutics-announces-the-appointment-of-cancer-immunotherapy-leader-jon-wigginton-m-,MGNX,0.046363,Neutral,-0.032716
Wall Street Analysts Predict a 291% Upside in MacroGenics  ( MGNX ) : Here's What You Should Know,20220812T135514,https://www.zacks.com/stock/news/1967763/wall-street-analysts-predict-a-291-upside-in-macrogenics-mgnx-heres-what-you-should-know,MGNX,0.287537,Somewhat-Bullish,0.306222
MacroGenics  ( NASDAQ:MGNX )  Rating Increased to Hold at StockNews.com,20220811T054441,https://reporter.am/2022/08/11/macrogenics-nasdaqmgnx-rating-increased-to-hold-at-stocknews-com.html,MGNX,0.945234,Bullish,0.408776
"After a covid-fuelled adrenaline rush, biotech is crashing",20220810T165426,https://www.economist.com/business/2022/08/10/after-a-covid-fuelled-adrenaline-rush-biotech-is-crashing,MGNX,0.068306,Neutral,0.035205
MacroGenics  ( NASDAQ:MGNX )  Upgraded by StockNews.com to Hold,20220810T082042,https://www.defenseworld.net/2022/08/10/macrogenics-nasdaqmgnx-upgraded-by-stocknews-com-to-hold.html,MGNX,0.878204,Bullish,0.390253
"MacroGenics Jumps Biotech Layoff Bandwagon, Cuts 15% Of Workforce",20220809T192330,https://www.benzinga.com/general/biotech/22/08/28422918/macrogenics-jumps-biotech-layoff-bandwagon-cuts-15-of-workforce,MGNX,0.330654,Somewhat-Bullish,0.195886
MacroGenics  ( MGNX )  Q2 2022 Earnings Call Transcript,20220809T043033,https://www.fool.com/earnings/call-transcripts/2022/08/09/macrogenics-mgnx-q2-2022-earnings-call-transcript/,MGNX,0.122894,Neutral,0.107564
"MacroGenics  ( MGNX )  Reports Q2 Loss, Tops Revenue Estimates",20220808T212511,https://www.zacks.com/stock/news/1965574/macrogenics-mgnx-reports-q2-loss-tops-revenue-estimates,MGNX,0.40348,Neutral,-0.002779
National Vision  ( EYE )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?,20220804T140031,https://www.zacks.com/stock/news/1963942/national-vision-eye-expected-to-beat-earnings-estimates-can-the-stock-move-higher,MGNX,0.17179,Neutral,-0.01428
Provention Bio Reports Second Quarter 2022 Financial Results and Provides Business Update,20220804T110852,https://www.prnewswire.com/news-releases/provention-bio-reports-second-quarter-2022-financial-results-and-provides-business-update-301599729.html,MGNX,0.016963,Neutral,0.097912
ImmunoGen  ( IMGN )  Q2 Earnings and Revenues Miss Estimates,20220801T151300,https://www.zacks.com/stock/news/1961446/immunogen-imgn-q2-earnings-and-revenues-miss-estimates,MGNX,0.040829,Neutral,-0.086252
Analysts Estimate MacroGenics  ( MGNX )  to Report a Decline in Earnings: What to Look Out for,20220801T140103,https://www.zacks.com/stock/news/1961349/analysts-estimate-macrogenics-mgnx-to-report-a-decline-in-earnings-what-to-look-out-for,MGNX,0.259267,Neutral,-0.03018
ImmunoGen  ( IMGN )  Q2 2022 Earnings Call Transcript,20220730T153040,https://www.fool.com/earnings/call-transcripts/2022/07/30/immunogen-imgn-q2-2022-earnings-call-transcript/,MGNX,0.008282,Neutral,0.1108
LeMaitre Vascular  ( LMAT )  Lags Q2 Earnings Estimates,20220728T215513,https://www.zacks.com/stock/news/1960184/lemaitre-vascular-lmat-lags-q2-earnings-estimates,MGNX,0.205807,Neutral,0.099479
MacroGenics Announces Date of Second Quarter 2022 Financial Results Conference Call,20220725T200100,https://www.benzinga.com/pressreleases/22/07/g28193912/macrogenics-announces-date-of-second-quarter-2022-financial-results-conference-call,MGNX,0.827318,Somewhat-Bullish,0.174048
Analysts Cuts Price Target On MacroGenics - Read Why,20220712T175642,https://www.benzinga.com/general/biotech/22/07/28038349/analysts-cuts-price-target-on-macrogenics-read-why,MGNX,0.71174,Somewhat-Bearish,-0.192174
Why MacroGenics Stock Tumbled Today,20220711T162834,https://www.fool.com/investing/2022/07/11/why-macrogenics-stock-tumbled-today/,MGNX,0.622414,Neutral,0.010863
"The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death",20220711T125503,https://www.benzinga.com/general/biotech/22/07/28015717/the-daily-biotech-pulse-europe-approves-second-round-of-booster-doses-of-mrna-covid-19-vaccines-p,MGNX,0.119532,Neutral,0.0
Patient Death Prompts MacroGenics To Close Mid-Stage Head & Cancer Study,20220711T104013,https://www.benzinga.com/general/biotech/22/07/28013761/patient-death-prompts-macrogenics-to-close-mid-stage-head-cancer-study,MGNX,0.686739,Neutral,0.0
MacroGenics Announces Closure of CP-MGA271-06 Study Evaluating Enoblituzumab plus Checkpoint Inhibition in Head and Neck Cancer,20220708T203000,https://www.globenewswire.com/news-release/2022/07/08/2476816/0/en/MacroGenics-Announces-Closure-of-CP-MGA271-06-Study-Evaluating-Enoblituzumab-plus-Checkpoint-Inhibition-in-Head-and-Neck-Cancer.html,MGNX,0.361228,Neutral,0.043495
Why MacroGenics Stock Is Skyrocketing Today,20220621T171050,https://www.fool.com/investing/2022/06/21/why-macrogenics-stock-is-skyrocketing-today/,MGNX,0.803474,Neutral,0.101819
MacroGenics to Participate in Upcoming Investor Conference,20220608T200100,https://www.benzinga.com/pressreleases/22/06/g27617431/macrogenics-to-participate-in-upcoming-investor-conference,MGNX,0.885864,Neutral,0.015312
Stocks That Hit 52-Week Lows On Tuesday,20220607T161020,https://www.benzinga.com/markets/options/22/06/27591585/52-weeks-high-and-low-article,MGNX,0.044543,Neutral,-0.010577
Stocks That Hit 52-Week Lows On Monday,20220606T181151,https://www.benzinga.com/markets/options/22/06/27570135/52-weeks-high-and-low-article,MGNX,0.065443,Neutral,-0.007354
Stocks That Hit 52-Week Lows On Friday,20220527T192849,https://www.benzinga.com/markets/options/22/05/27444271/52-weeks-high-and-low-article,MGNX,0.077144,Neutral,-0.003379
Stocks That Hit 52-Week Lows On Wednesday,20220525T161423,https://www.benzinga.com/markets/options/22/05/27398602/52-weeks-high-and-low-article,MGNX,0.023585,Neutral,0.003627
MacroGenics Announces Appointment of William Heiden to Board of Directors,20220523T200100,https://www.benzinga.com/pressreleases/22/05/g27357395/macrogenics-announces-appointment-of-william-heiden-to-board-of-directors,MGNX,0.400838,Somewhat-Bullish,0.176615
MacroGenics to Participate in Upcoming Investor Conference,20220517T200100,https://www.benzinga.com/pressreleases/22/05/g27264299/macrogenics-to-participate-in-upcoming-investor-conference,MGNX,0.873061,Neutral,0.014048
ImmunoGen  ( IMGN )  Q1 2022 Earnings Call Transcript,20220506T173035,https://www.fool.com/earnings/call-transcripts/2022/05/06/immunogen-imgn-q1-2022-earnings-call-transcript/,MGNX,0.006535,Neutral,0.03298
12 Health Care Stocks Moving In Thursday's Intraday Session,20220505T173930,https://www.benzinga.com/trading-ideas/movers/22/05/27030409/12-health-care-stocks-moving-in-thursdays-intraday-session,MGNX,0.137632,Neutral,0.000632
Provention Bio Reports First Quarter 2022 Financial Results and Provides Business Update,20220505T110000,https://www.prnewswire.com/news-releases/provention-bio-reports-first-quarter-2022-financial-results-and-provides-business-update-301540118.html,MGNX,0.015834,Neutral,0.022545
81 Biggest Movers From Yesterday,20220505T083133,https://www.benzinga.com/news/22/05/27012598/81-biggest-movers-from-yesterday,MGNX,0.045786,Neutral,0.00079
50 Stocks Moving In Wednesday's Mid-Day Session,20220504T174548,https://www.benzinga.com/news/22/05/26999516/50-stocks-moving-in-wednesdays-mid-day-session,MGNX,0.063375,Neutral,0.000234
Why MacroGenics Stock Is Tanking Today,20220504T164715,https://www.fool.com/investing/2022/05/04/why-macrogenics-stock-is-tanking-today/,MGNX,0.743296,Somewhat-Bearish,-0.204578
"MacroGenics  ( MGNX )  Reports Q1 Loss, Lags Revenue Estimates",20220503T211508,https://www.zacks.com/stock/news/1914810/macrogenics-mgnx-reports-q1-loss-lags-revenue-estimates,MGNX,0.375345,Neutral,-0.129442
MacroGenics Announces Date of First Quarter 2022 Financial Results Conference Call,20220425T201200,https://www.globenewswire.com/news-release/2022/04/25/2428554/0/en/MacroGenics-Announces-Date-of-First-Quarter-2022-Financial-Results-Conference-Call.html,MGNX,0.799215,Neutral,0.029984
MacroGenics Announces Date of First Quarter 2022 Financial Results Conference Call,20220425T201156,https://www.benzinga.com/pressreleases/22/04/g26799943/macrogenics-announces-date-of-first-quarter-2022-financial-results-conference-call,MGNX,0.778291,Neutral,0.02928
Stocks That Hit 52-Week Lows On Friday,20220422T162629,https://www.benzinga.com/markets/options/22/04/26764450/52-weeks-high-and-low-article,MGNX,0.012589,Neutral,-0.029535
"I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2021",20220329T101000,https://www.prnewswire.com/news-releases/i-mab-provides-business-and-corporate-updates-and-reports-financial-results-for-the-year-ended-december-31-2021-301512585.html,MGNX,0.013564,Neutral,0.033633
Molecular Partners AG  ( MOLN )  Q4 2021 Earnings Call Transcript,20220316T190029,https://www.fool.com/earnings/call-transcripts/2022/03/16/molecular-partners-ag-moln-q4-2021-earnings-call-t/,MGNX,0.005608,Bearish,-0.551011
